Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 Posters are placed in numerical order in the following categories: в—Џв—Џ BASIC SCIENCE LIVER в—Џв—Џ LUMINAL CLINICAL в—Џв—Џ BASIC SCIENCE LUMINAL в—Џв—Џ MOTILITY/NEUROGASTROENTEROLOGY в—Џв—Џ ENDOSCOPY – LOWER в—Џв—Џ NUTRITION в—Џв—Џ ENDOSCOPY – UPPER в—Џв—Џ PAEDIATRICS в—Џв—Џ HEPATOLOGY – CLINICAL в—Џв—Џ VIRAL HEPATITIS в—Џв—Џ IBD – CLINICAL BASIC SCIENCE LIVER 18 THE PROTEASE FIBROBLAST ACTIVATION PROTEIN (FAP) IN LIVER DISEASE Mark Gorrell, Kathryn Williams, Ana Julia Viera de Ribeiro, Sumaiya Chowdhury, Elizabeth Hamson, Oliver Schilling, Emilia Prakoso, Nicholas Shackel, Susan McLennan, William Bachovchin, Fiona Keane, Geoffrey McCaughan, Amany Zekry, Stephen Twigg 46 DELETION OF THE CYTOPLASMIC DOMAIN OF TISSUE FACTOR AMELIORATES LIVER FIBROSIS AND DECREASES TGF Β EXPRESSION IN A MURINE MODEL OF CIRRHOSIS Virginia Knight, Jorge Tchongue, Dinushka Lourensz, Alison Liu, Peter Tipping, William Sievert 56 THE POTENTIAL ROLE OF LIPOPOLYSACCHARIDES IN THE DEVELOPMENT OF BILIARY INJURY IN AN ANIMAL PARTIAL LIVER ISCHAEMIA MODEL Janske Reiling, KR Bridle, N Santrampurwala, LJ Britton, DHG Crawford, CHC Dejong, J Fawcett 66 ANGIOTENSIN CONVERTING ENZYME 2 (ACE2) GENE THERAPY USING A HIGH EFFICIENCY AND LIVER-SPECIFIC ADENOASSOCIATED VIRAL VECTOR ATTENUATES EXPERIMENTAL LIVER FIBROSIS IN MICE Kai Yan Mak, Ruth Chin, Joe Torresi, Sharon Cunningham, Ian Alexander, Peter Angus, Chandana Herath 83 JAGGED2 IS A MASTER REGULATOR OF LIVER CANCER STEM CELL Guang Wu, Guang Wu, George Wilson, Jacob George, Liang Qiao 84 TLR9 MAY BE A DOUBLE EDGED SWORD IN THE LIVER: IS IT PATHOGENIC OR PROTECTIVE IN NASH? Auvro Mridha, Fahrettin Haczeyni, Matthew Yeh, Geoff Haigh, Vanessa Barn, Hussam Ajamieh, Jeffrey Hamdorf, Leon Adams, Narci Teoh Geoffrey Farrell 87 THE ROLE OF RECEPTOR-MEDIATED ENDOCYTOSIS OF H-FERRITIN-INDUCED PROINFLAMMATORY SIGNALLING IN HEPATIC STELLATE CELLS Grant Ramm, Manuel Fernandez-Rojo, Anita Burgess, Amber Glanfield, Diem Hoang-Le, Nathan Subramaniam, Grant Ramm 168 SPACIOTEMPORAL CHARACTERIZATION OF THE CELLULAR AND MOLECULAR CONTRIBUTORS TO CHRONIC HEPATIC FIBROSIS IN A HEPATOTOXIN-INDUCED MOUSE MODEL Michelle Melino, Victoria Gadd, Michelle Martinez, Katie Lineburg, Katharine Irvine, Andrew Clouston, Elizabeth Powell, Kelli MacDonald 13 Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 224 EXERCISE SLOWS GROWTH OF DYSPLASTIC HEPATOCYTES BY IMPROVING INSULIN SENSITIVITY AND ENHANCING DNA DAMAGE SURVEILLANCE PATHWAYS IN MICE GENETICALLY PREDISPOSED TO OBESITY AND DIABETES Evi Arfianti, Vanessa Barn, W Geoffrey Haigh, George N Ioannou, Narci Teoh, Geoff Farrell 242 THE ROLE OF ADIPONECTIN AND T-CADHERIN INTERACTIONS IN LIVER FIBROSIS Badr ALzahrani 247 WHAT CAUSES KUPFFER CELL ACTIVATION IN NAFLD? HMGB1, TLR4, CRYSTALS AND NLRP3 INFLAMMASOME LINK FREE CHOLESTEROL TO INHIBITABLE PRO-INFLAMMATORY PATHWAYS IN NASH Lay T Gan, Derrick M Van Rooyen, Matthew Cooper, Avril Robertson, Seth Masters, Narci Teoh, Geoff Farrell 250 MANIPULATION OF DIETARY ADVANCED GLYCATION END-PRODUCT CONTENT INFLUENCES THE PROGRESSION OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) Christopher Leung, CB Herath, J Zhiyuan, T Leong, JM Forbes, PW Angus 271 INVESTIGATION OF MICE DEFICIENT IN MATRIPTASE-2, HFE AND TRANSFERRIN RECEPTOR 2 REVEALS A NOVEL NONHEPATIC ROLE FOR TFR2 IN ERYTHROPOIESIS Daniel Wallace, Eriza Secondes, Gautam Rishi, Lesa Ostini, Cameron McDonald, Steven Lane, John Hooper, Carlos Lopez-Otin, V. Nathan Subramaniam 292 SERUM-FREE HEPATOCYTIC TRANSDIFFERENTIATION OF PANCREATIC PROGENITOR CELLS FACILITATED BY EXTRACELLULAR MATRIX PROTEINS Nina Tirnitz-Parker, Francis Gratte, John Olynyk, George Yeoh, David Tosh, Deirdre Coombe 294 A NOVEL FLEXIBLE ENDOSCOPY-CAPABLE OXYGEN PROBE CAN DETECT PANCREATIC ISCHEMIA IN A RAT MODEL OF CHRONIC PANCREATITIS Payal Saxena, Sandeep Akshintala, Brian Simons, Kathleen Gabrielson, Vivek Kumbhari, Pankaj Pasricha, Vikesh Singh, Mouen Khashab, Anthony Kalloo 299 HEPATIC MICRORNA EXPRESSION IS ALTERED IN A MURINE MODEL OF IRON AND FAT CO-MEDIATED LIVER INJURY Cameron McDonald, Yin Yuan, Nishreen Santrampurwala, Darrel Crawford, Nathan Subramaniam 303 HEAT SHOCK PROTEIN 47 IS A POTENTIAL THERAPEUTIC TARGET FOR THE DEPLETION OF CANCER-PROMOTING STROMAL CELLS IN PANCREATIC CANCER Phoebe Phillips, Janet Youkhana, Joshua McCarroll, George Sharbeen, Mert Erkan, Jie Liu, David Goldstein BASIC SCIENCE LUMINAL 14 17. APPLICABILITY OF NEXT GENERATION SEQUENCING TECHNOLOGY IN MICROSATELLITE INSTABILITY TESTING Chun Gan, Clare Love, Victoria Beshay, Finlay Macrae, Stephen Fox, Paul Waring, Graham Taylor 20. POLYMORPHISMS IN C. CONCISUS ZOT AFFECT THE CLEAVAGE OF ZOT PROTEINS BY BACTERIAL PROTEASES Vikneswari Mahendran, Hoyul Lee, Fang Liu, Sheryln Sabrina, Rena Ma, Stephen M Riordan, Michael C Grimm, Li Zhang 21. THE EFFECTS OF GASTROINTESTINAL ENVIRONMENTAL FACTORS ON CAMPYLOBACTER CONCISUS GROWTH Rena Ma, Nicholas Sapwell, Hoyul Lee, Vikneswari Mahendran, Rupert Leong, Michael Grimm, Stephen Riordan, Li Zhang 22. DETECTION OF THE ZONULA OCCLUDENS TOXIN EXPRESSED IN CAMPYLOBACTER CONCISUS STRAINS Hoyul Lee, Fang Liu, Vikneswari Mahendran, Li Zhang Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 34. MODELLING THE EARLY DYSPLASTIC CHANGES IN COLITIS-ASSOCIATED COLORECTAL CANCER USING SPONTANEOUS MURINE COLITIS Sarron Randall-Demllo, Raj Eri, Anthony Cook, Dane Hayes, Kevin Spring 35. AQUEOUS RHUBARB EXTRACT IMPROVES ILEAL MUCOSAL INTEGRITY AND REDUCES ACUTE INFLAMMATION IN A RAT MODEL OF 5-FLUOROURACIL-INDUCED INTESTINAL MUCOSITIS Juliana Bajic, Georgina Eden, Lorrinne Lampton, Ker Cheah, Kerry Lymn, Andrea Yool, Gordon Howarth 36. OSTRICH OIL FAILED TO IMPROVE INTESTINAL BARRIER FUNCTION FOLLOWING 5-FLUOROURACIL-INDUCED MUCOSITIS IN RATS Juliana Bajic, Ker Cheah 37. ESCHERICHIA COLI NISSLE 1917 DERIVED FACTORS REDUCE CELL DEATH, LATE APOPTOSIS AND INCREASE TRANSEPITHELIAL ELECTRICAL RESISTANCE IN A MODEL OF 5-FLUOROURACIL-INDUCED INTESTINAL EPITHELIAL CELL DAMAGE Juliana Bajic, Hanru Wang, Susan Bastian, Ker Cheah, Andrew Lawrence, Suzanne Mashtoub, Gordon Howarth 38. FACTORS DERIVED FROM ESCHERICHIA COLI NISSLE 1917, GROWN IN DIFFERENT GROWTH MEDIA, ENHANCE CELL DEATH IN A MODEL OF 5-FLUOROURACIL-INDUCED CACO-2 INTESTINAL EPITHELIAL CELL DAMAGE Juliana Bajic, Hanru Wang, Susan Bastian, Andrew Lawrence, Suzanne Mashtoub, Gordon Howarth 39. EMU OIL IN COMBINATION WITH LYPRINOLв„ў REDUCES SMALL INTESTINAL DAMAGE ASSOCIATED WITH CHEMOTHERAPYINDUCED MUCOSITIS IN RATS Juliana Bajic, Lorrinne Lampton, Georgina Eden, Ker Cheah, Kerry Lymn, Suzanne Mashtoub, Gordon Howarth 49. APPEARANCE OF TUMOR-DERIVED METHYLATED DNA IN PLASMA CORRELATES WITH COLORECTAL TUMOUR INVASION Dileep Mangira, Ronan Baker, Erin Symands, Stephen Cole, Libby Bambacas, Susanne Pederson, David Murray, Lawrence LaPointe, Greame Young 79. INTEGRATED GENOME WIDE DNA METHYLATION AND GENE EXPRESSION ANALYSIS IDENTIFIES SUBGROUPS OF COLORECTAL CANCER WITH DISTINCT MOLECULAR AND CLINICAL FEATURES Troy Dumenil 92. ISOCITRATE DEHYDROGENASE 1 R132C MUTATION OCCURS EXCLUSIVELY IN MICROSATELLITE STABLE COLORECTAL CANCERS WITH THE CPG ISLAND METHYLATOR PHENOTYPE Vicki Whitehall, Troy Dumenil, Diane McKeone, Catherine Bond, Mark Bettington, Ron Buttenshaw, Lisa Bowdler, Grant Montgomery, Leesa Wockner, Barbara Leggett 94. RNF43 IS A FREQUENT MUTATIONAL TARGET IN THE SERRATED PATHWAY OF COLORECTAL CARCINOGENESIS Vicki Whitehall, Diane McKeone, Jonathan Ellis, Catherine Bond, Mark Bettington, Sally Pearson, Barbara Leggett 128. TUBULOVILLOUS ADENOMA WITH PROMINENT ARCHITECTURAL SERRATION – A CLINICOPATHOLOGICAL AND MOLECULAR APPRAISAL OF A NEW SUBTYPE OF COLORECTAL POLYP Neal Walker, Ian Brown, Christophe Rosty, Andrew Clouston, Sally-Ann Pearson, Diane McKeone, Barbara Leggett, Vicki Whitehall 129. CHANGING INCIDENCE OF BRAF AND KRAS MUTATIONS IN COLORECTAL CARCINOMA Mark Bettington, Ian Brown, Neal Walker, Christophe Rosty, Andrew Clouston, Sally-Ann Pearson, Diane McKeone, Barbara Leggett, Vicki Whitehall 130. WNT SIGNALING IN AN UNSELECTED SERIES OF COLORECTAL CARCINOMAS Mark Bettington, Catherine Bond, Ian Brown, Neal Walker, Christophe Rosty, Andrew Clouston, Sally-Ann Pearson, Diane McKeone, Barbara Leggett, Vicki Whitehall 15 Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 16 165. DIFFERENTIAL EFFECTS BETWEEN PROTON PUMP INHIBITORS ON CLOPIDOGREL-MEDIATED ANTI-PLATELET INHIBITION Paul Spizzo, Samantha Cole 174. METHYLATION AND EXPRESSION OF THE TUMOUR SUPPRESSOR, PRDM5, IN COLORECTAL CANCER SUBGROUPS Catherine Bond 181. HYPOXIA INDUCIBLE FACTOR 1α (HIF-1α) REGULATES ANTI-INFLAMMATORY LYMPHOID RESPONSES DURING COLITIS Ellen Marks, Gavin Nolan, Sean Mateer, Kyra Minahan, Bridie Goggins, Jocelle Cardona, Simon Keely 184. OBESE VISCERAL ADIPOSE TISSUE EXHIBITS ALTERED T CELL TRAFFICKING PATTERNS AND CONFERS A UNIQUE PHENOTYPE TO TISSUE- RESIDENT T CELLS Sukanya Raghuraman, Andrew R Lloyd, Amany Zekry 187. IMMUNE CELL MIS-HOMING DRIVES SECONDARY ORGAN INFLAMMATION IN INFLAMMATORY BOWEL DISEASE; A FOCUS ON THE RESPIRATORY SYSTEM Sean Mateer, Steven Maltby, Ellen Marks, Bridie Goggins, Jay Horvat, Philip Hansbro, Simon Keely 219. RETINOIC ACID IS REQUIRED FOR THE GENERATION OF PROTECTIVE APPENDICEAL REGULATORY T CELLS Annie Luo, Andrew Lim, Hye-Jee Jung, Phillips Phoebe, Michael Grimm 225. RECREATING THE INTESTINAL MACROPHAGE IN VITRO: A POTENTIAL ROLE FOR STROMAL FACTORS Greta Lee, Michael Grimm 227. THE IMPACT OF APPENDICITIS ON RORGAMMAT+ INNATE LYMPHOID CELLS Louis Yeung, Michael Grimm 234. HYPOXIA INDUCIBLE FACTOR (HIF)-1 ACCELERATES EPITHELIAL WOUND HEALING THROUGH INTEGRIN REGULATION Bridie Goggins, Kyra Minahan, Ellen Marks, Sean Mateer, Jocelle Cardona, Darryl Knight, Jay Horvat, Simon Keely 236. ORAL NUCLEOTIDES ONLY MINIMALLY IMPROVE 5-FLUOROURACIL-INDUCED MUCOSITIS IN RATS Juliana Bajic, Suzanne Mashtoub, B Feo, Alexander Whittaker, Kerry Lymn, D Marinez-Puig, Gordon Howarth 237. THE ROLE OF ANTIBIOTICS IN THE DEVELOPMENT OF FOOD ALLERGY Jocelle Cardona, Ellen Marks, Bridie Goggins, Sean Mateer, Kyra Minahan, Jay Horvat, Simon Keely 239. SAFETY OF EMU OIL FOR INTESTINAL APPLICATIONS Juliana Bajic, Suzanne Mashtoub, Ker Cheah, Gordon Howarth 241. EMU OIL SOURCE DOES NOT SIGNIFICANTLY ALTER THERAPEUTIC EFFICACY, WHILST OSTRICH OIL HAS NO BENEFICIAL EFFECT, IN A RAT MODEL OF CHEMOTHERAPY-INDUCED MUCOSITIS Juliana Bajic, Suzanne Mashtoub, Ker Cheah, NLC Lansdown, Gordon Howarth 243. ACUTE TUMOUR NECROSIS FACTOR ADMINISTRATION INDUCES TRANSIENT EPITHELIAL CELL SHEDDING, MUCOSAL LEAK AND NEUTROPHIL RECRUITMENT TO THE GUT IN A MOUSE MODEL Jeff Chang, Rupert Leong, Mehreen Arshi, Tri Phan, Antony Kelleher, Mark Danta 261. THE MAJOR PATHWAY BY WHICH POLYMERIC FORMULA REDUCES INTESTINAL INFLAMMATION IN CROHN’S DISEASE PATIENTS - A MICROARRAY-BASED ANALYSIS Steven Leach, Lily Nahidi, J Wei, Daniel Lemberg, Andrew Day Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 288. ASSOCIATION OF SEROLOGICAL EPITHELIAL COMPONENT PROTEINS WITH COMPLICATED CROHN’S DISEASE BY DISCOVERY AND VERIFICATION PHASE PROTEOMICS Yunki Yau, Rupert WL. Leong, Aviv Puddipeddi, Varan Perananthan, Diane Redmond, Jeff Chang, Valerie C. Wasinger 317. INSTITUTING MODERN MANAGEMENT OF EOSINOPHILIC ESOPHAGITIS IN AUSTRALIA; LESSONS FROM OUR FIRST 65 PATIENTS USING A STRUCTURED CLINICAL ALGORITHM Hamish Philpott, Sanjay Nandurkar, Peter Gibson 340. THE INSIGHT VARIANT INTERPRETATION COMMITTEE – STANDARDISED CLASSIFICATION OF MISMATCH REPAIR GENE VARIANTS IN LYNCH SYNDROME Finlay Macrae, Bryony Thompson, John-Paul Plazzer, Amanda Spurdle ENDOSCOPY – LOWER 11. OPTIMISATION OF ENDOSCOPIC FOLLOW-UP WAITING LISTS IN A NEW ZEALAND DISTRICT HEALTH BOARD Neeraj Bhala, Helen Myint, Joan Lewis, Carey Virtue, Adam Simpson, Rees Cameron 24. EFFECT OF SPLIT-DOSE BOWEL PREPARATION ON POLYP DETECTION RATE AND ADENOMA DETECTION RATE IN A REGIONAL SETTING IN VICTORIA Neel Heerasing, Barry Morphett 41. ENDOSCOPIC MANAGEMENT OF LARGE SESSILE SERRATED ADENOMAS IS SAFE AND EFFECTIVE: OUTCOMES FROM A MULTICENTRE PROSPECTIVE COHORT STUDY Maria Pellise, Nicholas Burgess, Nicholas Tutticci, Luke F Hourrigan, Simon A Zanatti, Gregor J Brown, Rajvinder Singh, Stephen J Williams, Spiro C Raftopoulos, Alan Moss, Donald G Ormonde, Heok P’Neg, Duncan Mc Leod, Michael J Bourke 43. PROSPECTIVE CHARACTERISATION OF THE MUCOSAL DEFECT AFTER COLD SNARE POLYPECTOMY Nicholas Tutticci, Nicholas Burgess, Maria Pellise, Duncan Mcleod, Michael J Bourke 48. THE ROLE OF A UNIVERSAL OR SELECTIVE ENDOSCOPIC SUBMUCOSAL DISSECTION STRATEGY FOR LARGE SESSILE AND LATERALLY SPREADING COLORECTAL TUMOURS IN A WESTERN TERTIARY REFERRAL CENTRE Farzan Bahin, Khalid Rasouli, Duncan McLeod, Hema Mahajan, Stephen Williams, Eric Lee, Rebecca Sonson, Michael Bourke 104. RATES OF COLONOSCOPY IN THE 3 YEARS PRIOR TO A DIAGNOSIS OF COLORECTAL CANCER IN WESTERN AUSTRALIA: ASSESSMENT OF RISK FACTORS FOR MISSED AND INTERVAL CANCERS. PRELIMINARY RESULTS FROM A POPULATIONBASED STUDY Salama Muna, Harma Claire 111. THE ADDITION OF HISTOLOGY TO CONTINUOUS AUDIT HAS SIGNIFICANTLY INCREASED ADENOMA DETECTION RATE IN A PRIVATE ENDOSCOPY UNIT Alan Fraser, Greg Gamble, Toby Rose 113. THE FINANCIAL BURDEN OF POOR BOWEL PREPARATION IN COLORECTAL CANCER SCREENING IN A TERTIARY HOSPITAL OUT-PATIENT DEPARTMENT Kendall Williams, Jenny McDonald, Thomas Lee, Ria Kanazaki 132. TERMINAL ILEAL INFLAMMATION IS ONLY SIGNIFICANT IN AN APPROPRIATE CLINICAL CONTEXT Shara Ket, Gillian Skardoon, Sheetal Deshpande, Haque Tasneem, Stephen Pianko 17 Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 18 134. IMPROVED STRATIFICATION OF SUBMUCOSAL INVASIVE CANCER RISK IN ADVANCED MUCOSAL NEOPLASIA OF THE COLON BY INTEGRATING GROSS MORPHOLOGY, SURFACE CHARACTERISTICS AND LOCATION: RESULTS FROM A LARGE MULTICENTER COHORT Nicholas G Burgess, Luke F Hourigan, Simon A Zanati, Gregor J Brown, Rajvinder Singh, Stephen J Williams, Spiro C Raftopoulos, Alan Moss, Donald Ormonde, Michael J Bourke 137. THE HISTOPATHOLOGICAL CORRELATES OF TWO ELECTROSURGICAL RESECTION MODALITIES IN AN IN-VIVO PORCINE MODEL OF ENDOSCOPIC MUCOSAL RESECTION Nicholas G Burgess, Farzan F Bahin, Maria Pellise, Rebecca Sonson, Rafael Perez-Dye, Shahrir Kabir, Vishnu Subramanian, Hema Mahajan, Duncan J McLeod, Michael J Bourke 162. EXTENDED WIDE FIELD ENDOSCOPIC MUCOSAL RESECTION IS NOT EFFECTIVE FOR REDUCING THE RISK OF RECURRENCE AFTER WF-EMR OF ADVANCED COLONIC MUCOSAL NEOPLASIA Maria Pellise, Nicholas G Burgess, Farzan F Bahin, Rebecca Sanson, Alsthensiel Golo, Stephen J Williams, Eric Lee, Hema Mahajan, Duncan J McLeod, Michael J Bourke 171. SALVAGE COLONOSCOPY USING COMBINED DISTAL CAP ATTACHMENT AND WATER INSUFFLATION IN PATIENTS WITH PREVIOUS FAILED OR INCOMPLETE COLONOSCOPY: A CASE SERIES Sze Pheh Yeap, William Tam 175. SERVICE AND QUALITY IMPROVEMENT: ADVANCED HIGH DEFINITION ENDOSCOPY IMPROVES POLYP DETECTION RATES – AN UNFAIR ADVANTAGE? – THE PRINCE CHARLES (TPCH) EXPERIENCE Ben Law, Ann Vandeleur, Endoscopy Nurses Collabor ENC, Suresh Ponneswamy, Mark Appleyard, John Croese, Ruth Hodgson, Tony Rahman 176. INTRODUCTION OF COLON CAPSULE ENDOSCOPY IN AUSTRALIA Finlay Macrae, Francesco Amico, Emma McLaughlin, Gabriel Segal 177. SERVICE AND QUALITY IMPROVEMENT: SPLIT BOWEL PREP IMPROVES POLYP DETECTION RATES AND OTHER QUALITY INDICATORS FOR COLONOSCOPY COMPARED TO STANDARD BOWEL PREPARATION – THE PRINCE CHARLES EXPERIENCE Ben Law, Ha Nguyen, Endoscopy Nurses Collabor ENC, Suresh Ponneswamy, Mark Appleyard, John Croese, Ruth Hodgson, Tony Rahman 186. A SYSTEMATIC REVIEW OF THE PERFORMANCE AND COST-EFFICIENCY OF NURSE AND NON-PHYSICIAN ENDOSCOPISTS Gerald Holtmann, Maximilian Stephens, Luke Hourigan, Mark Appleyard, George Ostapowicz, Mark Schoeman, Paul Desmond, Jane Andrews, Michael Bourke, David Hewitt, David Margolin 193. CONFOCAL LASER ENDOMICROSCOPY IN THE ASSESSMENT OF MUCOSAL EPITHELIAL BARRIER DEFECTS IN INFLAMMATORY BOWEL DISEASES: INTER-, INTRA-OBSERVER AGREEMENT, LEARNING CURVE AND ACCURACY Matthew Ip, Jeff Chang, Michael Yang, Brendon Wong, Tri Phan, Lisa Lin, Theresa Power, Rupert Leong 206. A PROSPECTIVE DUAL CENTRE EVALUATION OF NARROW BAND IMAGING (NBI) WITH A FIXED ZOOM FUNCTION IN REAL TIME PREDICTION OF POLYP HISTOLOGY. CAN WE RESECT AND DISCARD? Niketh Kuruvilla, Ramesh Paramsothy, Gill Raghubinder, Matthew Remedios, Warwick Selby, Arthur Kaffes 208. HIGH BMI: A RISK FACTOR FOR SIGNIFICANT COLONIC POLYPS Mohammed Alansari, C. Schepisi 213. QUALITY IN COLONOSCOPY: ADENOMA DETECTION RATE AUDIT IN AN AUSTRALIAN TERTIARY HOSPITAL Yong C Jonathan TAN, Richard La Nauze, Robyn Secomb, Catherine Bunn, Peter Gibson, Gregor J Brown Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 215. WIDE FIELD ENDOSCOPIC MUCOSAL RESECTION (WF-EMR) COMPARED TO SURGERY FOR LARGE SESSILE AND FLAT COLONIC POLYPS: ECONOMIC ANALYSIS Mahesh Jayanna, Nicholas Burgess, Rajvinder Singh, Luke Hourigan, Gregor Brown, Simon Zanati, Alan Moss, James Lim, Rebecca Sonson, Stephen Williams, Michael Bourke 226. ORAL REHYDRATION SOLUTION ORANGE VS BLACKCURRANT IN ADDITION TO STANDARD BOWEL PREPARATION FOR COLONOSCOPY: A PILOT STUDY Yong C Jonathan TAN, Richard La Nauze, Robyn Secomb, Catherine Bunn, Peter Gibson, Gregor J Brown 228. FACTORS INFLUENCING SESSILE SERRATED ADENOMA (SSA) DETECTION RATES AT A MULTI-CENTRE METROPOLITAN AUSTRALIAN HEALTH SERVICE Jeremy Dwyer, Alan Moss 229. CLINICAL SIGNIFICANCE OF SPORADIC LARGE SESSILE SERRATED ADENOMAS Mahesh Jayanna, Maria Pellise, Kavinderjit Nanda, Nicholas Burgess, Rebecca Sonson, Duncan McLeod, Hema Mahajan, Michael Bourke 233. SESSILE SERRATED ADENOMA AND OVERALL POLYP DETECTION RATES BETWEEN PENTAX AND OLYMPUS COLONOSCOPES IN A REGIONAL AUSTRALIAN HOSPITAL Seema Shah, David Whitaker 259. THE HISTOPATHOLOGIC EFFECTS OF ARGON PLASMA COAGULATION COMPARED WITH SNARE TIP SOFT COAGULATION IN AN IN-VIVO PORCINE MODEL OF ENDOSCOPIC MUCOSAL RESECTION Nicholas G Burgess, Farzan F Bahin, Maria Pellise, Sonson Rebecca, Rafael Perez-Dye, Shahrir Kabir, Vishnu Subramanian, Hema Mahajan, Duncan J McLeod, Michael J Bourke 284. ULCERATIVE COLITIS ENDOSCOPIC INDEX OF SEVERITY (UCEIS) HAS A SUPERIOR INTEROBSERVER AGREEMENT THAN THE MAYO ENDOSCOPIC SUBSCORE IN THE EVALUATION OF ULCERATIVE COLITIS ACTIVITY Liam Beiglari, Jeff Chang, Crispin Corte, Rupert Leong 289. ADENOMA DETECTION RATE AT A TERTIARY CENTRE Darren Wong, Poornima Varma, Peter Prichard 290. SESSILE SERRATED ADENOMA PREVALENCE IN COMMUNITY GASTROENTEROLOGY PRACTICE Georgia Hume, John Gibbons, Anthony Watt, John Pauli, Jillian Rosenstengel, Kate Cayzer, Paul Clark, Nicholas Tutticci 296. A NATIONAL SURVEY OF AUSTRALIAN ENDOSCOPISTS’ ATTITUDES TOWARDS NURSE ENDOSCOPY David Hewett, Ammar Kheir, Simone Mackrill, Lori Leach, Bernadette Watson 335. SIGNIFICANCE OF SMALL BOWEL LIPID DEPOSITS SEEN ON CAPSULE ENDOSCOPY Mian Li ooi, John Wettenhall, Kathryn Ogden 338. LONG-TERM OUTCOMES OF PALLIATIVE THERAPY FOR OBSTRUCTION CAUSED BY INCURABLE STAGE IV COLORECTAL CANCER IN PATIENTS WITH GOOD PERFORMANCE STATUS : ENDOSCOPIC STENT VERSUS SURGERY Ahn Hyo Jun, Kim Sang Woo, Moon Sung Jin, Lim Chul-Hyun, Kim Jin Su, Cho Yu Kyung, Park Jae Myung, Lee In Seok, Choi Myung-Gyu 19 Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 ENDOSCOPY – UPPER 20 1. ANTIPLATELET AND ANTICOAGULANT AGENT USE AT TIME OF GASTROINTESTINAL BLEEDING DOES NOT AFFECT CLINICAL OUTCOMES Ray Boyapati, Marcus Robertson, Avik Majumdar, William Chung, Rima Turbah, Rhys Vaughan, Steven Lontos 23. FIRST REPORTED GASTRIC EXPLOSION INDUCED BY ARGON PLASMA COAGULATION (APC): A DEVASTATING COMPLICATION PREVENTABLE BY A SIMPLE CHANGE IN ENDOSCOPIC PRACTICE John Freiman, Toni Hampe 26. PREVALENCE OF EOSINOPHILIC OESOPHAGITIS IN ADULTS PRESENTING WITH OESOPHAGEAL FOOD BOLUS OBSTRUCTION Neel Heerasing, Shok Yin Lee, Damian Dowling, Sina Alexander 27. PROSPECTIVE EVALUATION OF SIMPLIFIED ALGORITHM FOR EUS-GUIDED INTRA-HEPATIC BILIARY ACCESS AND ANTEROGRADE INTERVENTIONS FOR FAILED ERCP Frank Weilert, Ashlee Bluett, Gayleen Putt, Lynne Irving, Amanda Ireton 28. ENDOSCOPIC ULTRASOUND-GUIDED COELIAC PLEXUS NEUROLYSIS: 3 YEAR EXPERIENCE Frank Weilert, Ashlee Bluett, Gayleen Putt, Lynne Irving, Amanda Ireton 29. ENDOSCOPIC ULTRASOUND-GUIDED TRANSMURAL DRAINAGE OF PERI-PANCREATIC FLUID COLLECTIONS IS HIGHLY EFFECTIVE AS PRIMARY ENDOSCOPIC THERAPY Frank Weilert, Ashlee Bluett, Gayleen Putt, Lynne Irving, Amanda Ireton 44. ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION (EUS-FNA): EXPERIENCE OF A REGIONAL CENTRE IN AUSTRALIA Chuang Ming-yu, Pei Yi Ong, Scott Fanning 53. CAP-ASSISTED LIGATION ENDOSCOPIC MUCOSAL RESECTION (EMR) OF LOWER OESOPHAGEAL LESION: TISSUE ACQUISITION OR CURATIVE TREATMENT Frank Weilert, James Brooker, Graeme Dickson 69. BLOOD TRANSFUSION IS ASSOCIATED WITH INCREASED MORTALITY RATE IN UPPER GASTROINTESTINAL BLEEDING Kavitha Subramaniam, Katrina Spilsbury, Oyekoya T Ayonrinde, Faye Latchmiah, Aqif Mukhtar, James Semmens, John K Olynyk 71. SAFETY AND EFFICACY OF ENDOSCOPIC MANAGEMENT OF BARIATRIC SURGICAL COMPLICATIONS: A CASE SERIES Sze Pheh Yeap, Leong Paul, Aiden Tieu, Singh Rajvinder, Biju George, Nind Garry, William Tam 93. LEARNING CURVE FOR OPTICAL BIOPSY USING NARROW BAND IMAGING - CAN REAL-TIME TRAINING IMPROVE ACCURACY? Sneha John, Jiyoung Lee, Lea Wiggins 117. THE CURRENT PRACTICE OF ERCP IN AUSTRALIA: 2014 SURVEY Alvin Ting, Daniel Croagh, Michael Swan, David Devonshire, Sina Alexander 123. ERCP DURATION AND ITS RELATIONSHIP TO INDICATIONS AND COMPLICATIONS Mohit Shetti, Andrew Thomson, Teresa Neeman 143. RISK STRATIFICATION IN ACUTE UPPER GASTROINTESTINAL BLEEDING: AIMS65 IS SUPERIOR TO GLASGOW-BLATCHFORD AND ROCKALL SCORING SYSTEMS IN PREDICTING INPATIENT MORTALITY Avik Majumdar, Ray Boyapati, William Chung, Ryma Terbah, Tom Worland, James Wei, Steve Lontos, Rhys Vaughan, Marcus Robertson Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 172. CONFOCAL LASER ENDOMICROSCOPY IS EQUIVALENT TO HISTOLOGY IN THE DETECTION OF GLUTEN-FREE DIET EFFICACY IN COELIAC DISEASE Hadis Mirzaei, Caroline Fung, Rupert Leong 179. EARLY CAPSULE ENDOSCOPY IN OBSCURE GASTROINTESTINAL BLEEDING LEADS TO HIGHER DIAGNOSTIC YIELD AND A NEGATIVE CAPSULE STUDY IS A PREDICTOR OF LOW RE-BLEEDING RISK Shanela Sooben, Dev Segarajasingam, Charlie Viiala 180. SERVICE AND QUALITY IMPROVEMENT: вЂ�ENDOCLOT’ MODIFIED CARBON DIOXIDE DELIVERY SYSTEM ALLOWS SAFE AND PROLONGED USE IN COMPLEX ACUTE SEVERE UPPER GASTROINTESTINAL HAEMORRHAGE Danielle Ashe, Suresh Ponneswamy, Ann Vandeleur, Endoscopy Nurses Collabor ENC, Alison Kenny, Tony Rahman, Ruth Hodgson 200. DIAGNOSTIC YIELD OF SUREPATHВ® IN SOLID PANCREATIC AND GIST LESIONS Abdelrahim Azizi 216. ENDOSCOPIC TREATMENT OF BARRETT’S OESOPHAGUS WITH DYSPLASIA OR INTRAMUCOSAL CARCINOMA: EXPERIENCE AND OUTCOMES FROM AN AUSTRALIAN TERTIARY CENTRE Niroshan Muwanwella, Sherman Picardo, Chiang Siah 222. INTERNATIONAL MULTICENTRE EXPERIENCE WITH PERORAL ENDOSCOPIC MYOTOMY (POEM) FOR THE TREATMENT OF SPASTIC OESOPHAGEAL DISORDERS REFRACTORY TO MEDICAL THERAPY Vivek Kumbhari, Ahmed Messallam, Manvi Solanki, Manabu Onimaru, Payal Saxena, Ezra Teitelbaum, Michael Ujiki, Matthew Gitelis, Rani Modayil, Eric Hungness, Stavros Stavropoulos, Mohamad El Zein, Hironari Shiwaku, Rastislav Kunda, Alessandro Repici, Hitomi Minami, Philip Chiu, Jeffery Ponsky, Amit Maydeo, Haruhiro Inoue, Mouen Khashab 238. FIRST AUSTRALIAN EXPERIENCE USING THE NOVEL INSTINCT ENDOSCOPIC CLIP: A STUDY OF USABILITY AND OUTCOMES Emma Bayly, Jeremy Dwyer, Alan Moss 246. BALLOON ASSISTED CHOLANGIOSCOPY: WHICH OPTICAL FEATURES DIFFERENTIATE BETWEEN BENIGN AND NEOPLASTIC LESIONS? Mathew Keegan, Peter Lim, Rajvinder Singh, Philip Craig 251. PROSPECTIVE MULTICENTRE INTERNATIONAL STUDY ON EUS-GUIDED BILIARY DRAINAGE FOR PATIENTS WITH DISTAL MALIGNANT BILIARY OBSTRUCTION AND FAILED ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) Vivek Kumbhari, Payal Saxena, Carlo Fabbri, Ahmed Mesallam, Shyam Varadarajulu, Ilaria Tarantino, Rani Modayil, Stavros Stavropoulos, Manuel Perez-Miranda, Joseph Romagnuolo, Vinay Dhir 256. PANCREATIC SEROUS CYSTADENOMA-RELATED MORTALITY IS ALMOST NIL - RESULTS OF A MULTINATIONAL STUDY UNDER THE AUSPICES OF THE INTERNATIONAL ASSOCIATION OF PANCREATOLOGY AND THE EUROPEAN PANCREATIC CLUB Yawei Tang, Rupert Leong, Raghubinder Gill, Benedicte Jais, Phillipe Levy 258. A NOVEL FLEXIBLE 19-GAUGE EUS-FNA NEEDLE APPEARS SAFE AND EFFECTIVE FOR INTERVENTIONAL EUS: AN INTERNATIONAL MULTICENTRE EXPERIENCE Vivek Kumbhari, Payal Saxena, Irene PeГ±as, Carlos De la Serna, Alan Tieu, Manvi Solanki, Manie Juneja, Faud Maufa, Nadim Haddad, Sandeep Krishnan, Susana Gonazalez, Peter Renny, Christopher DiMaio, Jonathan Buscaglia, Manuel Perez-Miranda, Mouen Khashab 21 Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 22 266. UTILITY OF ENDOSCOPIC ULTRASONOGRAPHY FOR EVALUATION AND SURVEILLANCE OF GASTRIC SUBEPITHELIAL TUMOURS Matthew Smith, Andre Chong, Marcus Chin, Simon Edmunds, Spiro Raftopoulos, Ian Yusoff, Dev Segarajasingam, Chiang Siah 269. GASTRIC GASTROINTESTINAL STROMAL TUMOURS (GISTS): TO NEEDLE OR NOT? Matthew Smith, Andre Chong, Marcus Chin, Simon Edmunds, Spiro Raftopoulos, Ian Yusoff, Dev Segarajasingam, Chiang Siah 270. COMPARISON OF TWO NEEDLE ASPIRATION TECHNIQUES FOR ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION (EUS-FNA) IN SOLID PANCREATIC LESIONS: A PROSPECTIVE MULTICENTRE STUDY Payal Saxena, Vivek Kumbhari, Mohamad El Zein, Ahmed Abdelgelil, Sepiedeh Besharati, Ahmed Mesallam, Tyler Stevens, Eun Ji Shin, Vikesh Singh, Anne Marie Lennon, Marcia Canto, Mouen Khashab 272. LOW INCIDENCE OF RECURRENCE OF PIECEMEAL RESECTED LARGE COLONIC POLYPS USING UNDERWATER EMR Rees Cameron 273. EFFICACY AND SAFETY OF ERCP PERFORMED BY A NEWLY TRAINED AUSTRALIAN INTERVENTIONAL ENDOSCOPIST INCORPORATING MODERN TECHNIQUES TO ENHANCE CANNULATION AND PREVENT PANCREATITIS Shan Kannuthurai, Jeremy Dwyer, Alan Moss 274. INTERVENTIONAL DEEP ENTEROSCOPY IN PATIENTS WITH SURGICALLY ALTERED ANATOMY USING STANDARD ENDOSCOPES AND A THROUGH-THE-SCOPE-BALLOON Vivek Kumbhari, Payal Saxena, Andrew Storm, Manvi Solanki, Patrick Okolo III 287. RAPID PROGRESSION FROM LGD TO HGD BARRETT вЂ�S – MYTH OR REALITY Puneet Mahindra, Richard Williams, Paul Desmond, Andrew Taylor 302. ENDOSCOPIC RESECTION OF SPORADIC DUODENAL ADENOMAS IS SAFE AND EFFECTIVE - A PROSPECTIVE EXPERIENCE FROM A TERTIARY ENDOSCOPY CENTRE Amir Klein, Farzan Bahin, Dhruv Nayyar, Khalid Rasouli, Golo Ahlenstiel, Eric Lee, Stephen Williams, Michael Bourke 304. ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC CANCER Nicholas Tutticci, Amir Klein, Farzan Bahin, Dhruv Nayyar, Eric Lee, Michael J Bourke 315. BIODEGRADABLE STENT PLACEMENT TO TREAT POST BARIATRIC SURGERY LEAKS: A CASE SERIES Estella Johns, Patrick Walsh 319. EFFICACY OF VISCOUS BUDESONIDE SLURRY IN THE PREVENTION OF OESOPHAGEAL STRICTURE FORMATION POST ENDOSCOPIC MUCOSAL RESECTION OF BARRETT’S OESOPHAGUS WITH HIGH-GRADE DYSPLASIA AND EARLY OESOPHAGEAL ADENOCARCINOMA Farzan Bahin, Mahesh Jayanna, Stephen Williams, Lee Eric, Song Min, Rebecca Sonson, Michael Bourke 324. UNIFORMITY OF PRACTICE IN THE ABSENCE OF AN EVIDENCE BASE: OVERUSE OF PPI INFUSIONS IN A TERTIARY REFERRAL CENTRE James Fulforth, Evan Newnham, John Lubel 327. DIAGNOSTIC UTILITY OF ECHOTIP PROCORE 25-GAUGE NEEDLE FOR EUS-FNA OF CONSECUTIVE SOLID LESIONS OF THE GI TRACT Andrew St John, Nadia Maqboul, Saurabh Gupta Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 328. COMPARISON OF THE HISTOPATHOLOGICAL EFFECTS OF TWO ELECTROSURGICAL CURRENTS IN AN IN-VIVO PORCINE MODEL OF OESOPHAGEAL ENDOSCOPIC MUCOSAL RESECTION Farzan F Bahin, Nicholas G Burgess, Shahrir Kabir, Rafael Perez-Dye, Vishnu Subramanian, Duncan J McLeod, Hema Mahajan, Maria Pellise, Rebecca Sonson, Michael J Bourke 330. LONG TERM OUTCOMES OF A PRIMARY COMPLETE ENDOSCOPIC RESECTION STRATEGY FOR BARRETT’S OESOPHAGUS WITH HIGH-GRADE DYSPLASIA AND EARLY OESOPHAGEAL ADENOCARCINOMA Farzan Bahin, Mahesh Jayanna, Luke Hourigan, Reginald Lord, Whiteman David, Stephen Williams, Eric Lee, Min Song, Rebecca Sonson, Michael Bourke 334. PATTERNS OF ASPIRIN USE IN THE COMMUNITY Oyekoya Ayonrinde, Kavitha Subramaniam, Faye Latchmiah, Jacob Helenius, Kar Mun Ng, Meghan Kan, Katrina Spilsbury, James Semmens, Aqif Mukhtar, Michael Leahy, John K Olynyk HEPATOLOGY – CLINICAL 4. LIVER TRANSPLANTATION: A SYSTEMATIC REVIEW OF LONG-TERM QUALITY OF LIFE Linda Yang, Leonard Shan, Akshat Saxena, David Morris 13. THE PATTERN OF ALPHAFETOPROTEIN LEVEL HAS GREATER DIAGNOSTIC VALUE COMPARED TO ISOLATED VALUES IN PREDICTING THE PRESENCE OF HEPATOCELLULAR CARCINOMA Abhinav Vasudevan, Natalie Denyar, Kumanan Nalankilli, Anvesh Jackson, Cian Scanlon, Jarrod Greenhalgh, John Lubel 16. A COMPARISON OF FIBROSCAN AND SHORT WAVE ELASTOGRAPHY PERFORMED DURING CONVENTIONAL ULTRASONOGRAPHY TO ASSESS LIVER FIBROSIS Lindsay Mollison, Laurens Manning, Chris Welman, Lachlyn Ayers, Crystal Connelly, John Olynyk, Muhammad Zubair, Sam Galhenage, O T (Koya) Ayonrinde 19. AN ELF SCORE OF >=9.8 CAN IDENTIFY ADVANCED FIBROSIS IN AUSTRALIAN PATIENTS WITH CHRONIC LIVER DISEASE Kevin Fagan 45. EPIDEMIOLOGIC TRENDS IN MORTALITY OF CIRRHOSIS IN THE INTENSIVE CARE UNIT: A LARGE, AUSTRALASIAN, MULTICENTRE COHORT Avik Majumdar, Michael Bailey, William Kemp, Stuart Roberts, David Pilcher 54. EFFECT OF METABOLIC SYNDROME ON PATIENTS WITH VIRAL HEPATITIS TREATED WITH LOCAL REGIONAL THERAPY FOR HEPATOCELLULAR CARCINOMA Fei Chen, Jacob George, Amany Zekry 55. NON-ALCOHOLIC FATTY LIVER DISEASE INTERMITTENT FASTING TIME INTERVENTION (NIFTI): FASTING WITHOUT CALORIE RESTRICTION IMPROVES HEPATIC TRANSIENT ELASTOGRAPHY, VISCERAL ADIPOSITY AND INSULIN RESISTANCE COMPARED TO STANDARD CARE Alexander Hodge, Alexandra Mack, Caroline Tuck, Jorge Tchongue, Darcy Holt, William Sievert, Gregory Moore 57. PERCUTANEOUS THERMAL ABLATION FOR PRIMARY HEPATOCELULAR CARCINOMA: A SYSTEMATIC REVIEW AND METAANALYSIS Mohamed Asif Chinnaratha, Ming-yu (Anthony) Chuang, Robert Fraser, Richard Woodman, Alan Wigg 23 Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 24 58. SUCCESSFUL EX-VIVO NORMOTHERMIC OXYGENATED MACHINE PERFUSION OF HUMAN DONOR LIVERS Janske Reiling, DSR Lockwood, AH Simpson, CM Campbell, KR Bridle, N Santrampurwala, LJ Britton, DHG Crawford, CHC Dejong, J Fawcett 59. PREVALENCE OF BONE DISEASE IN CIRRHOSIS Mohamed Chinnaratha, Rosemary McCormick, Rachel Wundke, Richard Woodman, Alan Wigg 60. SERUM DICKKOPF-1, OSTEOPONTIN AND MIDKINE AS NOVEL BIOMARKERS FOR THE DIAGNOSIS AND PRE-CLINICAL DIAGNOSIS OF HEPATOCELLULAR CARCINOMA Roslyn Vongsuvanh, Jacob George, Tristan Iseli, Simone Strasser, Geoffrey McCaughan, David van der Poorten 61. NON-ALCOHOLIC FATTY LIVER DISEASE AND ALL-CAUSE AND CARDIOVASCULAR MORTALITY: A POPULATION BASED COHORT STUDY Suzanne Mahady, Germaine Wong, Robin Turner, Jonathan Craig, Jacob George 63. CAFFEINE CONSUMPTION IS NOT ASSOCIATED WITH DISEASE SEVERITY IN NAFLD David van der Poorten, Tommy Tran 64. SIMPLE SERUM MARKERS MODELS ACCURATELY PREDICT LIVER RELATED SURVIVAL, COMPLICATIONS AND HCC IN CHRONIC HCV INFECTION Yi Huang, Leon Adams, Gerry MacQuillan, Enrico Rossi, Max Bulsara, Gary Jeffrey 65. A NEW SERUM BIOCHEMICAL MODEL THAT ACCURATELY PREDICTS LIVER COLLAGEN PROPORTIONAL AREA Yi Huang, Bastiaan de Boer, Leon Adams, Gerry MacQuillan, Enrico Rossi, Max Bulsara, Gary Jeffrey 68. PREDICTORS OF ALCOHOL RECIDIVISM FOLLOWING LIVER TRANSPLANTATION FOR ALCOHOLIC LIVER DISEASE IN AN AUSTRALIAN POPULATION Dileep Mangira, Anthony Chuang, John Chen, Richard Woodman, Alan Wigg 72. CHOLESTATIC HEPATITIS C AFTER LIVER TRANSPLANTATION HAS A HIGH MORTALITY AND IS REFRACTORY TO INTERFERON THERAPY Talal Valliani, Ramesh Paramsothy, Geoff McCaughan, Simone Strasser 98. HIV IS ASSOCIATED WITH PROGRESSION OF LIVER STIFFNESS IN CHRONIC HEPATITIS C Nicole Wong, Stuart Roberts, Paula Lewis, Eldho Paul, Kitson Matt, David Iser, William Kemp 107. POST-PARTUM CARE OF WOMEN WITH HEPATITIS B AND THEIR BABIES Stephanie Spring, Lukas Sahhar, Natassia Tan, Phil Ha, Vanessa Bull, William Birkett, Joseph Lewis, Emily Licklitter, Trushna Trivedi, Suong Le, Anouk Dev 108. EPIDEMIOLOGY AND OUTCOMES OF PRIMARY SCLEROSING CHOLANGITIS PATIENTS IN AN AUSTRALIAN COHORT Ken Liu, Rosy Wang, Mark Wells, Simone Strasser, Geoff McCaughan, Crispin Corte, Rupert Leong 116. VACCINATION AND OPPORTUNISTIC TESTING FOR HEPATITIS B VIRUS AMONGST RELATIVES, HOUSEHOLD AND SEXUAL CONTACTS OF PATIENTS WITH CHRONIC HEPATITIS B Vanessa Bull, Phil Ha, Natassia Tan, Lukas Sahhar, Stephanie Spring, Suong Le, Anouk Dev 121. CONTRAST ENHANCED ULTRASOUND (CEUS) MAKES A SIGNFIICANT DIFFERENCE IN THE ASSESMENT OF INDETERMINATE LIVER LESIONS - AN AUSTRALIAN TERTIARY CENTRE EXPERIENCE Desmond Patrick, Niramjan Arachchi, Alan Moss, Ian Kronborg, Julian Nguyen Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 127. HEPATITIS C TREATMENT AND PROGRESSION OF LIVER STIFFNESS IN AUSTRALIA, SUBSEQUENT TO THE INTRODUCTION OF PROTEASE INHIBITORS Yang Wu, Martin Weltman, Guy Eslick 133. HEPATIC FIBROSIS IN AN ELDERLY POPULATION Martin Veysey, Way Siow, Suzanne Niblett, Katrina King, Zoe Yates, Mark Lucock 135. COMPARISON OF TRANSIENT ELASTOGRAPHY AND NAFLD FIBROSIS SCORE IN NON-ALCOHOLIC FATTY LIVER DISEASE Yang Wu, Martin Weltman, Guy Eslick 136. WHITE CELL COUNTS AND NON-ALCOHOLIC FATTY LIVER DISEASE Martin Veysey, Way Siow, Suzanne Niblett, Katrina King, Zoe Yates, Mark Lucock 141. COMPARISON OF NAFLD FIBROSIS SCORE (NFS) AND TRANSIENT ELASTOGRAPHY (FIBROSCANВ®), ALONE AND IN COMBINATION, AS NON-INVASIVE METHODS FOR THE EVALUATION OF FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) Edric Hee, William W. Kemp, Bastiaan de Boer, Jeffrey M. Hamdorf, Gerry C. MacQuillan, George Garas, Helena Ching, Ross MacNicholas, Stuart K. Roberts, Matthew T. Kitson, Gary P. Jeffrey, Leon Adams 145. THERAPEUTIC ABDOMINAL PARACENTESIS IN AN AMBULATORY SETTING: IS ROUTINE BLOOD CULTURE BOTTLE COCULTURE NECESSARY? Thomas Goodsall, Mahesh Menon, Steven Bollipo, John Ferguson 148. DEVELOPMENT OF AUTOIMMUNE TYPE I DIABETES MELLITUS DURING TREATMENT WITH PEGINTERFERON AND RIBAVIRIN FOR CHRONIC HEPATITIS C- A TERTIARY CENTRE EXPERIENCE Samarth Rao, Wendy Cheng 149. CANCER REGISTRIES UNDERESTIMATE HEPATOCELLULAR CARCINOMA INCIDENCE: AN INDEPENDENT POPULATION-BASED EPIDEMIOLOGICAL STUDY Thai Hong, Alexander Thompson, Paul Gow, Michael Fink, Anouk Dev, Virginia Knight, Marno Ryan, Ian Kronborg, Niranjan Arachchi, Stuart Roberts, William Kemp, Amanda Nicoll, John Lubel, Helen Farrugia, Vicky Thursfield, Paul Desmond, Sally Bell 153. TREATMENT SAFETY AND EFFICACY OF BOCEPREVIR-BASED TRIPLE THERAPY IN GENOTYPE 1 HEPATITIS C: THE AUSTRALIAN MULTICENTRE BOCEPREVIR REAL WORLD EXPERIENCE (SABRE-C) Anouk Dev, Joanne Mitchell, Kevan Polkinghorne, Richard Skoien, Katherine Stuart, Wendy Cheng, Alice Lee, Miriam Levy, John Lubel, Saroja Nazareth, Sherryne Warner, Alan Wigg, Stuart Roberts 154. HOSPITAL UTILIZATION IN PATIENTS WITH LIVER CIRRHOSIS AFTER ENROLMENT TO THE CHRONIC LIVER FAILURE PROGRAM Su Yin Lau, Richard Woodman, Rachel Wundke, Rosemary McCormick, Alan Wigg 155. ARE WE DOING ENOUGH? SCREENING AT-RISK PATIENTS FOR HEPATITIS B IN INFLAMMATORY BOWEL DISEASE CLINICS Edward Hao Jun Tsoi, Cheng Yee Goh, Niranjana Parthasarathy, Kaye Marion, Charys McNab, Simon Glance, Christopher Leung 158. IMPLICATIONS OF TREAT NOW VERSUS WAITING FOR NEWER THERAPEUTIC REGIMENS IN CHRONIC HEPATITIS C Gauri Mishra 25 Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 26 169. ANTIMITOCHONDRIAL ANTIBODIES (AMA) AND PRIMARY BILIARY CIRRHOSIS (PBC) – THE ST. VINCENT’S EXPERIENCE 2003 2013 Manjeet Sandhu, Alexander Thompson, Wanyuan Cui, Paul Desmond, Sally Bell, Marno Ryan, Barbara Demediuk, Robert Chen, David Iser, Gideon Shaw, Aaaron Bloch, Tin Nguyen 173. CASE CONTROL COHORT STUDY OF CANCER RATES IN SYNCHRONOUS PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE VERSUS PATIENTS WITH INFLAMMATORY BOWEL DISEASE ALONE Ken Liu, Rosy Wang, Viraj Kariyawasam, Paul Lunney, Mark Wells, Simone Strasser, Geoff McCaughan, Crispin Corte, Rupert Leong 183. INTEGRATED SAFETY ANALYSIS OF SOFOSBUVIR-BASED HCV TREATMENT REGIMENS FROM PHASE 3 STUDIES Alexander Thompson, S Gordon, W Towner, A Aggarwal, J Ma, J McNally, LM Stamm, DM Brainard, WT Symonds, JG McHutchison, N Bellos, K Tashima, N Afdhal 188. SOFOSBUVIR-BASED REGIMENS ARE ASSOCIATED WITH HIGH SVR RATES ACROSS GENOTYPES AND AMONG PATIENTS WITH MULTIPLE NEGATIVE PREDICTIVE FACTORS Alexander Thompson, GR Foster, SI Strasser, C Christensen, J Ma, N Bekele, DM Brainard, WT Symonds, JG McHutchison, B Conway, I Crespo, S Zeuzem 197. A COMBINED RULE BASED ON HBSAG LEVELS AND HBV DNA LEVELS PREDICTS RISK OF HBV REACTIVATION IN PATIENTS IN THE IMMUNE CONTROL PHASE OF CHB Gareth Burns, Jacinta Holmes, Rimma Goldberg, Rebecca Trethowan, Avelyn Wong, Oliver Cronin, Niketh Kuruvilla, Tin Nguyen, Raymond Shaw, Robert Chen, Barbara Demediuk, Sally Bell, Stephen Locarnini, Scott Bowden, Paul Desmond, Alexander Thompson 198. LONG TERM FOLLOW-UP OF PATIENTS TREATED WITH SOFOSBUVIR IN THE PHASE 3 STUDIES FISSION, POSITRON, FUSION AND NEUTRINO Wendy Cheng, S Shafran, K Beavers, H Mo, J McNally, DM Brainard, WT Symonds, M Chojkier, A Mangia, C Schwabe 199. UNDERSTANDING THE PHASES OF CHRONIC HEPATITIS B; THE PROBLEM AND A NOVEL SOLUTION USING RENAMED PHASES, THE HEPATITIS B BEAR AND A VIDEO (SEE “ UNDERSTANDING HEPATITIS B “ ON YOUTUBE) Heidi Lord, Carla Treloar, Elena Cama, Jamee Newland, Miriam Levy 202. PAIN CONTROL AND PREVENTION OF ENCEPHALOPATHY IN PATIENTS WITH CIRRHOSIS Vanessa Weerasinghe Mudiyansalage, Malcolm Hogg, Chatura Jayasekera, Amanda Nicoll 203. LIVER ULTRASOUND DOES NOT ACCURATELY PREDICT TRANSIENT ELASTOGRAPHY DIAGNOSED CIRRHOSIS Charitha Ranaweera, Oyekoya Ayonrinde, Mollison Lindsay, Sam Galhenage, John Olynyk 207. SOFOSBUVIR IN COMBINATION WITH PEG IFN AND RIBAVIRIN FOR 12 WEEKS PROVIDES HIGH SVR RATES IN HCV-INFECTED GENOTYPE 2 OR 3 TREATMENT EXPERIENCED PATIENTS WITH AND WITHOUT COMPENSATED CIRRHOSIS: RESULTS FROM THE LONESTAR-2 STUDY Stephen Pianko, E Lawitz, F Poordad, DM Brainard, RH Hyland, D An, WT Symonds, JG McHutchison 209. THE LANDSCAPE OF HEPATITIS B WOMEN IN A SINGLE CENTRE Enoka Gonsalkorala, Miriam Levy, Vi Nguyen, Carina Burns, Anne Glass 210. HEPATITIS C MANAGEMENT EXPERIENCE IN A REGIONAL HOSPITAL Mohammed Alansari, C. Schepisi, K. Simpson, L. Johnston, C. Sainsbury Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 211. ACOUSTIC RADIATION FORCE IMPULSE (ARFI) ELASTOGRAPHY HAS A WEAK CORRELATION WITH CHILD PUGH GRADE AND THE PRESENCE OF COMPLICATIONS David Nadebaum, Robert Gibson, Jessica Howell, John Halliday, Alexandra Gorelik, Danny Liew, Amanda Nicoll 212. INCIDENCE AND RISK FACTORS ASSOCIATED WITH VOLATILE ANAESTHETIC DRUG INDUCED LIVER INJURY (VALDA PROJECT): INTERIM ANALYSIS Nicholas Hannah, Brad Hockey, David Moore, Jonathan Lin, Dolores Njoku, Adam Doyle, Fransesco Amico, Alexandra Gorelik, Danny Liew, John Halliday, Amanda Nicoll 214. A QUALITATIVE ASSESSMENT OF KNOWLEDGE, PERCEPTION AND HEALTH EXPECTATIONS AMONGST PATIENTS WITH CHRONIC HEPATITIS B Natassia Tan, Vanessa Bull, Phil Ha, Lukas Sahhar, Stephanie Spring, Suong Le, Anouk Dev 218. HEPATIC FIBROSIS REGRESSION IN HEPATITIS B COHORT ON LONG-TERM ORAL ANTIVIRAL THERAPY Christine Verdon, Stephen Oh, Christopher Kiely, Ross Hansen, Jocelyn Schramko, Venessa Pattullo, Brett Jones 221. SOFOSBUVIR COMPASSIONATE USE PROGRAM FOR PATIENTS WITH SEVERE RECURRENT HEPATITIS C INCLUDING FIBROSING CHOLESTATIC HEPATITIS FOLLOWING LIVER TRANSPLANTATION Simone Strasser, X Forns, M Prieto, M Charlton, JG McHutchison, WT Symonds, J Denning, T Brandt-Sarif, P Chang, V Kivett, TF Baumert, A Coilly, F Habersetzer 230. REAL WORLD EFFICACY AND SAFETY WITH DIRECT ACTING ANTIVIRAL DRUGS IN CHRONIC HEPATITIS C - WESTERN AUSTRALIAN EXPERIENCE Samarth Rao, Wendy Cheng 231. CT HEPATIC ANGIOGRAPHY VERSUS BIOPSY IN THE DIAGNOSIS OF RADIOLOGIC ATYPICAL HEPATOCELLULAR CARCINOMA – AN EVALUATION OF REAL LIFE PRACTICE Desmond Patrick, Stephen Bloom, Manfred Spanger, Vivek Ramachandran, John Lubel 235. NON-INVASIVE BIOMARKERS ARE SUPERIOR TO CLINICAL MEASURES IN PREDICTING HEPATIC DECOMPENSATION AFTER LIVER RESECTION James Thomas, Raj Ashok, Uthayanam Chelvaratnam, Marrianne Black, Linda Fletcher, Caroline Tallis, Gerald Holtmann, Jonathan Fawcett, Katherine Stuart 248. ULTRASOUND (US) GUIDED PERCUTANEOUS LIVER BIOPSY OUTCOMES AT A TERTIARY HOSPITAL – A COMPARISON BETWEEN GASTROENTEROLOGY ADVANCED TRAINEE VERSUS RADIOLOGIST-PERFORMED PROCEDURES Sivathasan Sellathurai, Gregory Carter, Aidan Foy, Lay Gan, Simon King, Robert Foster 253. ACOUSTIC RADIATION FORCE IMPULSE IMAGING (ARFI) IN THE ASSESSMENT OF LIVER FIBROSIS; AN ANALYSIS OF PERFORMANCE WITHIN A вЂ�REAL-LIFE’ AUSTRALIAN SETTING David Nadebaum, Robert Gibson, Jessica Howell, John Halliday, Michael Christie, Alexandra Gorelik, Danny Liew, Amanda Nicoll 254. GOOD TRANSIENT ELASTOGRAPHY INTER-OBSERVER REPRODUCIBILITY IN A NURSE-LED FIBROSCAN CLINIC AT A SINGLE TERTIARY CENTRE Nadine Leembruggen, Saroj Nazareth, Terri Budge, Sook-Ling Chen, Eng Gan, Cheng Wendy 260. MICROBIAL BURDEN IS ASSOCIATED WITH CLINICAL OUTCOMES AND REDUCED ASCITES INNATE IMMUNE CELLS IN NONINFECTED ASCITES Katharine Irvine, Kevin Fagan, Michelle Melino, Elizabeth Powell 43 Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 44 262. PREDICTORS OF INPATIENT MORTALITY IN CIRRHOTICS IN THE INTENSIVE CARE UNIT: A TASMANIAN EXPERIENCE Sern Wei Yeoh, Karen Wills, Ted Stoklosa, Karl Vaz, Shamim Samedani, Maneesha Bhullar, Rajesh Bhatia 268. INTER-OPERATOR CONCORDANCE IN ACOUSTIC RADIATION FORCE IMPULSE IMAGING (ARFI); A PRACTICAL ROLE FOR MULTIPLE OPERATORS TO IMPROVE DIAGNOSTIC PERFORMANCE David Nadebaum, Robert Gibson, Jessica Howell, John Halliday, Michael Christie, Alexandra Gorelik, Danny Liew, Amanda Nicoll 277. FALSE POSITIVE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA IN A MULTIDISCIPLINARY LIVER CLINIC Toni Hampe, Betty Wu, Francis Chu, John Freiman 278. WEIGHT GAIN AFTER LIVER TRANSPLANT OCCURS EARLY AND IS UNRELATED TO THE EMOTIONAL STATE AND EATING BEHAVIOURS USUALLY SEEN IN OBESITY Simone McCoy, Katrina Campbell, Maree Jarrett, Jonathan Fawcett, Graeme Macdonald, Ingrid Hickman 280. EVALUATION OF PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH HCC UNDERGOING TREATMENT WITH TRANSARTERIAL CHEMOEMBOLISATION: IMPORTANCE OF CLIP RATHER THAN HAP SCORE Christabel Kelly, Pamela Crest, Eldho Paul, Paula Lewis, William Kemp, Stuart Roberts 283. IMPROVED PREDICTION OF LIVER FIBROSIS AND PROBABILITY OF NASH IN PATIENTS WITH NAFLD BY COMBINING LIVER STIFFNESS WITH CLINICOPATHOLOGICAL AND BIOMARKER MEASUREMENTS Gan Lay Theng, Lay T Gan, Bruce Shadbolt, Vincent Wong, Leon Adams, Teddi Dwyer, Henry Chan, Narci Teoh, Shiv Chitturi, Geoff Farrell 295. PERCUTANEOUS TRANSHEPATIC VARICEAL EMBOLISATION - FIRST CASE REPORTS IN AN AUSTRALIAN SETTING Aviv Pudipeddi, Mark Danta, Robert Feller, Arti Rattan, Joga Chaganti 301. PRE-OPERATIVE CARDIORESPIRATORY FITNESS AND POST-OPERATIVE CARDIOMETABOLIC DISEASE IN LIVER TRANSPLANT RECIPIENTS Matthew Wallen, Jeff Coombes, Graeme Macdonald, Aidan Woodward, Tina Skinner 309. NONINVASIVE TESTING INCLUDING INDOCYANIN GREEN CLEARANCE IN PREDICTION OF CLINICALLY SIGNIFICANT PORTAL HYPERTENSION Sarah Gardner 325. THE CHANGING RISK FACTOR PROFILE OF HEPATOCELLULAR CARCINOMA: EXPERIENCES FROM A WESTERN AUSTRALIAN TERTIARY CENTRE Sherman Picardo, Jee Kong, Lorenzo Tarqunio, Nick Kontorinis, Wendy Cheng 326. EUS-GUIDED BILIARY DRAINAGE PERFORMED BY HEPATOGASTROSTOMY VS. CHOLEDOCHODUODENOSTOMY: AN INTERNATIONAL MULTICENTER COMPARATIVE STUDY IN 150 PATIENTS Vivek Kumbhari, Payal Saxena, Yousuke Nakai, Rani Modayil, Carlos De La Serna, Kazuo Hara, Stavros Stavropoulos, Manuel Perez-Miranda, Vinay Dhir, Do Hyun Park, Mouen Khashab 329. SOFOSBUVIR AND RIBAVIRIN FOR THE TREATMENT CHRONIC HCV WITH CIRRHOSIS AND PORTAL HYPERTENSION WITH AND WITHOUT DECOMPENSATION: EARLY VIROLOGIC RESPONSE AND SAFETY Geoffrey McCaughan, N Afdhal, G Everson, JL Calleja, WT Symonds, J Denning, L McNair, JG McHutchison, S Arterburn, M Charlton, R Reddy, T Asselah, E Gane, X Forns Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 332. REGRESSION OF ADVANCED FIBROSIS FOLLOWING VIROLOGICAL RESPONSE TO ANTI-HCV THERAPY Marianne Martinello, Dianne How-Chow, Mark Danta, Gail Matthews, Greg Dore 333. SAFETY AND EFFICACY OF TELAPREVIR AND BOCEPREVIR IN THE “REAL WORLD”: AN AUSTRALIAN EXPERIENCE Marianne Martinello, Dianne How-Chow, Mark Danta, Gail Matthews, Greg Dore IBD – CLINICAL 7. INCIDENCE OF PAEDIATRIC IBD IN NEW SOUTH WALES, AUSTRALIA INCREASES THROUGH 1968-2013 Cheng Hiang Lee, Rupert W Leong, Edward V O’Loughlin, Kevin J Gaskin 15. CAECAL TUBERCULOSIS MASQUEADING AS INFLAMMATORY BOWEL DISEASE Kate Napthali, Robert Foster 25. DOES LYMPHOPENIA OR MACROCYTOSIS REFLECT THERAPEUTIC 6-THIOGUANINE LEVELS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH AZATHIOPRINE OR 6-MERCAPTOPURINE? Neel Heerasing, Jer Fuu Ng, Damian Dowling, Christopher Hair 51. ACCELERATED 1-HR INFLIXIMAB INFUSIONS ARE SAFE AND COST EFFECTIVE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE Guang Chen, Payal Saxena, Glen Collins, Rupert Leong 77. ADALIMUMAB ACHIEVES EFFICACY IN MUCOSAL HEALING REGARDLESS OF BASELINE DISEASE SEVERITY IN PATIENTS WITH CROHN’S DISEASE: DATA FROM EXTEND Nicolas Martin, William Sandborn, Douglas Wolf, Jean-Frederic Colombel, Julian Panes, Samantha Eichner, Annalisa Iezzi, Qian Zhou, Anne Robinson, Roopal Thakkar 82. INFLIXIMAB SALVAGE OUTCOMES IN ACUTE SEVERE COLITIS IN A SINGLE AUSTRALIAN INFLAMMATORY BOWEL DISEASE CENTRE: HIGHLY EFFICACIOUS, COST EFFECTIVE AND PBS LISTED Abhinav Vasudevan, Jarrod Greenhalgh, Cian Scanlon, Asiri Arachchi, Ramessh Ranjan, Elliott Freeman, Sanjay Nandurkar, Daniel van Langenberg 85. THIRD PARTY FUNDING FOR FAECAL CALPROTECTIN IS LIKELY TO REDUCE COLONOSCOPY USAGE IN AUSTRALIA: GASTROENTEROLOGISTS’ USE AND KNOWLEDGE OF ITS ROLE IN CLINICAL PRACTICE Omar Elnawsra, Ian Fok, Susan Connor, Miles Sparrow, Peter Gibson, Jane Andrews 86. OUTCOMES OF SALVAGE THERAPY FOR ACUTE SEVERE COLITIS TREATMENT IN A SINGLE TERTIARY CENTRE: INFLIXIMAB V. CYCLOSPORINE Sophie Shepherd, Emily K Wright, Jacinta A Holmes, Steven J Brown, Mark Lust, Michael A Kamm, Sally J Bell, William Connell 90. ANTI-TNF THERAPY USE IN PREGNANT PATIENTS WITH CROHN’S DISEASE AND ULCERATIVE COLITIS Christopher Kiely, Kavitha Subramanian, Paul Pavli 95. FAECAL CALPROTECTIN – IMPACT ON TIMING OF COLONOSCOPY IN IBD PATIENTS Ria Kanazaki, Thomas Lee, Claudia Rogge, Arthur Grillas, Jenny Roberts, Jennifer McDonald, Hung Chieng 102. MEDICATION ADHERENCE IN TRANSITIONAL INFLAMMATORY BOWEL DISEASE PATIENTS: A MULTI-CENTRE PILOT STUDY Jayson Jeganathan, Cheng Hiang Lee, Antony Rahme, Darren Tiao, Celine Weston, Shoma Dutt, Annabel Magoffin, Vu Kwan, Peter Katelaris, Christian Selinger, Kevin Gaskin, Ted O’Loughlin, Rupert Leong 45 Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 46 105. RATIONALE, STUDY DESIGN AND INTERIM DATA FROM THE ALIGN STUDY: A MULTI-COUNTRY, CROSS-SECTIONAL, EPIDEMIOLOGICAL STUDY EVALUATING BELIEFS AND CONCERNS ABOUT SYSTEMIC MEDICATION IN 6 CHRONIC INFLAMMATORY DISEASES Nicolas Martin, Pierre Michetti, John Weinman, Ulrich Mrowietz, Josef Smolen, Dieter Schremmer, Jingdong Chao, Nicole Selenko-Gebauer 109. IMPACT OF TARGETED PHARMACIST COUNSELLING INTERVENTION ON IBD MEDICATION ADHERENCE Darren Tiao, Jayson Jeganathan, Andy Chen, Jeff Chang, Christian Selinger, Rupert Leong 114. SEX-RELATED DIFFERENCES IN DISEASE COURSE AND PATIENT OUTCOME IN THE SYDNEY IBD COHORT Paul Lunney, Viraj Kariyawasam, Rosy Wang, Kate Middleton, Tony Huang, Christian Selinger, Jane Andrews, Peter Katelaris, Rupert Leong 115. ADALIMUMAB AND INFLIXIMAB LEVELS IN NEONATES CORRELATE WITH DURATION OF TREATMENT IN PREGNANCY (ERA STUDY) Mette Julsgaard, Lisbet A Christensen, Peter R Gibson, Jan Fallingborg, Richard Gearry, Alissa Walsh, William Connell, Jens Kjeldsen, Miles P Sparrow, Graham Radford-Smith, Jane M. Andrews, Ian Lawrence, Signe Wildt, Gregory T Moore, Lise Svenningsen, Ourania Rosella, Anne Grosen, Sally J Bell 122. METHOTREXATE CAN NAUSEATE, MORE THAN WE ANTICIPATE : CAN WE ALEVIATE (IN IBD)? Desmond Patrick, Lauren Beswick, Daniel van Langenberg 124. THE FIRST PROSPECTIVE AUSTRALIAN POPULATION-BASED NATURAL HISTORY STUDY OF NEWLY DIAGNOSED IBD IDENTIFIES FREQUENT USE OF IMMUNOMODULATORS AND LOW SURGERY RATES Ola Niewiadomski, Corrie Studd, Chris Hair, Wilson Jarrad, Nik Ding, Neel Heerasing, Alvin Ting, John McNeill, Ross Knight, Paul Dabkowski, Emily Prewett, Sina Alexander, Damian Dowling, Ben Allen, Benjamin Popp, Paul Desmond, William Connell, Sally Bell 125. SOCIAL FACTORS THAT AFFECT ATTENDANCE RATES IN A METROPOLITAN INFLAMMATORY BOWEL DISEASE CLINIC Cheng Yee Goh, Edward Hao Jun Tsoi, Charys McNab, Alvin Chung, Simon Glance 140. THE EFFECTS OF VITAMIN D DEFICIENCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE Amanda Lim, Soong-Yuan Ooi, Robert Bryant, CG Schultz, Charlotte Goess, JC Hughes, Dylan Bartholomeusz, Jane M Andrews 144. THE UTILITY OF MAGNETIC RESONANCE ENTEROGRAPHY IN DIAGNOSIS AND MANAGEMENT CHANGES IN CROHN’S DISEASE Chamara Basnayake, Gregory Moore 146. INFLIXIMAB VERSUS CYCLOSPORINE IN SEVERE, STEROID-REFRACTORY ULCERATIVE COLITIS; A COMPARISON OF CLINICAL OUTCOMES Matija Radojcic, Finlay Macrae, Bernadette Viney 151. THIOPURINE PRESCRIBING AND MONITORING BEHAVIOUR, INCLUDING METABOLITES TESTING AND ALLOPURINOL COTHERAPY: AN AUSTRALIAN PERSPECTIVE FROM 2008 TO 2013 Kenny Ching Pan Sze, Amanda Siriwardana, Wa Sang Watson Ng, Susan Jane Connor, Alexandra Sechi 156. LONG-TERM SAFETY OF ONCE-DAILY MULTIMATRIX MESALAZINE: A POOLED CLINICAL TRIALS ANALYSIS Susana D. Silva Sanchez, Hong Wan, Paul Streck, Deborah Willshire, Jeffrey B. Raskin Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 157. THE EFFECTIVENESS OF SHORT-TERM AND LONG-TERM DAILY TREATMENT WITH MULTIMATRIX MESALAZINE ON IMPROVING WORK-RELATED OUTCOMES IN ADULT PATIENTS WITH MILD-TO-MODERATE ULCERATIVE COLITIS Deborah Willshire, Mary Kaye Willian, Aaron Yarlas, Ashish V. Joshi 161. TRANSITION IBD PATIENTS: A CHALLENGING AND COMPLICATED POPULATION Matthew Choy, Alexandra Murphy, Aaron Bloch, Alex Thompson, Mark Lust, Steven Brown, Emily Wright, Michael Kamm, George Alex, William Connell, Sally Bell 164. CUTANEOUS MANIFESTATIONS OF ANTI-TUMOUR NECROSIS FACTOR (ANTI-TNF) THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): A CASE SERIES Faseeha Peer, Kavitha Subramaniam, Paul Pavli 167. FORWARD-VIEWING COLONOSCOPY VERSUS FULL-SPECTRUM ENDOSCOPY (FUSE) FOR DYSPLASIA DETECTION WITH AND WITHOUT CHROMOENDOSCOPY IN INFLAMMATORY BOWEL DISEASES: A PROSPECTIVE, RANDOMIZED-ORDER, CROSSOVER TANDEM SURVEILLANCE COLONOSCOPY STUDY Marie Ooi, James Panetta, Corte Crispin, Rupert Leong 191. IS GEOGRAPHIC VARIABILITY OF INCIDENCE AND PREVALENCE OF CROHN’S DISEASE LINKED TO HELICOBACTER PYLORI? AN ECOLOGIC STUDY Gerald Holtmann, Ayesha Shah, Nicholas Talley, Marjorie Walker, Natasha Koloski, Erin Shanahan, Mark Morrison, Daniel Burger, Jane Andrews, Michael McGuckin, Mike Jones 192. HIGHER RED BLOOD CELL METHOTREXATE POLYGLUTAMATES CORRELATE WITH INCREASED DISEASE ACTIVITY, AND ARE USEFUL IN ASSESSING ADHERENCE Mark Ward, Fong Steven, Ikram Nasr, Rishi Goel, Kamal Patel, Monica Arenas Hernandez, Antony Marinaki, Jeremy Sanderson, Peter Irving 217. THIOPURINE METABOLITE MONITORING IN INFLAMMATORY BOWEL DISEASE (IBD): A RETROSPECTIVE OBSERVATIONAL STUDY EVALUATING THE LONGER-TERM OUTCOMES (GREATER THAN OR EQUAL 12 MONTHS) OF METABOLITE LEVEL LED CLINICAL MANAGEMENT – PRELIMINARY FINDINGS Soong-Yuan Ooi, Jane Andrews, Susan Connor, Peter Bampton, Michael Gounder, Rachel Grafton, Peta Leach, Watson Ng 223. IMPAIRED MUCOSAL PERMEABILITY UNDERLIES ONGOING IRRITABLE BOWEL SYNDROME-LIKE SYMPTOMS, IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE WHO HAVE ACHIEVED MUCOSAL HEALING Jeff Chang, Matthew Ip, Michael Yang, Brendon Wong, Mehreen Arshi, Tri Phan, Rupert Leong 282. POOR INFLAMMATORY BOWEL DISEASE-RELATED KNOWLEDGE IN MIDDLE EASTERN AND CAUCASIAN PATIENTS IS ASSOCIATED WITH A KNOWLEDGE DEFICIT GRADIENT Rhys Butcher, Crispin Corte, Gavin Barr, Grace Chapman, James Cowlishaw, David Brian Jones, Peter Katelaris, Charles McDonald, John McLaughlin, Simon Campbell, Rupert Leong 286. LONG-TERM OUTCOMES IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH INFLIXIMAB OR ADALIMUMAB IN AN AUSTRALIAN REGIONAL CENTRE Jeremy Dwyer, Diane Lim, Brent Mitchell 291. COMPLEMENTARY AND ALTERNATIVE MEDICINE (CAM) USE FOR INFLAMMATORY BOWEL DISEASE IS COMMON IN BOTH MIDDLE EASTERN AND CAUCASIAN PATIENTS Rhys Butcher, Crispin Corte, Gavin Barr, Grace Chapman, James Cowlishaw, David Brian Jones, Peter Katelaris, Charles McDonald, John McLaughlin, Simon Campbell, Rupert Leong 47 Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 297. INFLIXIMAB INFUSION PROTOCOLS ARE TIME CONSUMING AND SEVERE INFUSION REACTIONS ARE RARE - IS IT TIME FOR CHANGE? Lauren Beswick, Lionel Soh, Anne McFarlane, Daniel van Langenberg 298. REINDUCTION OF ADALIMUMAB AND INFLIXIMAB AFTER SECONDARY LOSS OF RESPONSE IN AN AUSTRALIAN IBD CENTRE: AN EFFECTIVE STRATEGY Belinda Jackson, Daniel Van Langenberg, Anne McFarlane 305. CONSISTENTLY HIGH C REACTIVE PROTEIN AND PLATELET COUNT ARE ASSOCIATED WITH DEVELOPMENT OF PERIANAL FISTULAE IN PATIENTS WITH CROHN’S DISEASE James Irwin, Emma Ferguson, Lisa Simms, Katherine Hanigan, Graham Radford-Smith 312. GENETIC ANALYSIS OF ESCHERICHIA COLI, FOCUSING ON ADHERENT, INVASIVE E. COLI ISOLATED FROM CROHN’S DISEASE PATIENTS Claire O’Brien, Paul Pavli, David Gordon 314. CONSISTENTLY LOW HAEMOGLOBIN LEVEL, LOW ALBUMIN LEVEL AND HIGH PLATELET COUNT ARE ASSOCIATED WITH SUBSEQUENT OBJECTIVE POOR OUTCOME IN PATIENTS WITH CROHN’S DISEASE James Irwin, Emma Ferguson, Lisa Simms, Katherine Hanigan, Graham Radford-Smith 316. HLA B27 IN CROHN’S DISEASE Katerina Liew, Graham Radford-Smith 331. PREVALENCE AND OUTCOMES OF CLOSTRIDIUM DIFFICILE INFECTION IN ADULT INFLAMMATORY BOWEL DISEASE PATIENTS COMPARED TO AGE AND SEX MATCHED CONTROLS: AN AUSTRALIAN SINGLE CENTRE EXPERIENCE Desmond Patrick, Daniel Van Langenberg 337. HOSPITALIZATION AND TREATMENT COSTS FOR ACUTE, SEVERE, STEROID-REFRACTORY ULCERATIVE COLITIS: INFLIXIMAB BEATS CICLOSPORIN Graham Radford-Smith, Phoebe Thwaites, James Irwin, Nicole Walker, Anna McMahon, Karen Sewell, Anthony Croft, David Clark, Mariko Howlett LUMINAL CLINICAL 48 5. SIDE EFFECTS ARE SIDE ISSUES: COMPLETENESS OF REPORTING OF HARMS AMONG SYSTEMATIC REVIEWS IN GASTROENTEROLOGY Suzanne Mahady, Timothy Schlub, Lisa Bero, David Moher, David Tovey, Jacob George, Jonathan Craig 8. TOPICAL STEROID THERAPY FOR THE TREATMENT OF EOSINOPHILIC OESOPHAGITIS (EOE) - A SYSTEMATIC REVIEW AND META-ANALYSIS Chuang Ming-yu, Mohamed Chinnaratha, Richard Woodman, Charles Cock, Robert Fraser 9. OBSTACLES TO DONOR RECRUITMENT FOR FAECAL MICROBIOTA TRANSPLANTATION – EXPERIENCES FROM THE FOCUS STUDY Sudarshan Paramsothy, Thomas Borody, Enmoore Lin, Sarah Finalyson, Alissa Walsh, Douglas Samuel, Johan van den Bogaerde, Mitchell Hazel, Nadeem Kaaokoush, Michael Kamm 30. THE SIGNIFICANCE OF DUODENAL THICKENING ON COMPUTERISED TOMOGRAPHY(CT) Zaid Ardalan, Gregory Moore Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 31. AMONGST PATIENTS WITH CT DIAGNOSIS OF COLON THICKENING , HOW DOES THE CLINICAL PRESENTATION CORRELATE WITH THE HISTOLOGIC DIAGNOSIS? Zaid Ardalan, Sujievan Chandranm, Gregory Moore 47. CLINICAL IMPLICATIONS OF DELAYED SURVEILLANCE COLONOSCOPY IN AN ABOVE AVERAGE RISK POPULATION: DATA FROM A LARGE REGIONAL REGISTRY Chuang Ming-yu, Erin Symonds, Charles Cock, Richard Woodman, Samhita Penukonda, Stephen Cole, Peter Bampton,Robert Fraser 67. ENDOSCOPIC INVESTIGATION IN IRON DEFICIENCY COMPARED WITH NON-IRON DEFICIENCY ANAEMIA Tamara Mogilevski, Adam Testro, Patrick Charles, Rhys Vaughan, Leonid Cherilov, Douglas Johnson, Rebecca Smith 75. SYMPTOMS AT PRESENTATION DO NOT DIFFERENTIATE PATIENTS WITH COELIAC DISEASE FROM IRRITABLE BOWEL SYNDROME AND FUNCTIONAL DYSPEPSIA James Hunt, Andrew Keegan, Marjorie Walker, Cheng Liu 89. HELICOBACTER PYLORI DIAGNOSED DURING ENDOSCOPY: TREATMENT AND FOLLOW-UP Dileep Mangira, Ming-Yu (Anthony) Chuang, Samantha Cole, Grace Seiboth, Stamatiki Kritas, Carly Burgstad, Charles Cock 101. FACTORS INFLUENCING FAECAL IMMUNOCHEMICAL TEST POSITIVITY RATE: DEMOGRAPHIC, PATHOLOGICAL, BEHAVIORAL AND ENVIRONMENTAL EFFECTS Erin Symonds, Joanne Osborne, Stephen Cole, Peter Bampton, Robert Fraser, Graeme Young 103. A METHYLATED DNA BLOOD TEST FOR COLORECTAL CANCER SCREENING RETURNS A LOWER FALSE POSITIVITY RATE THAN A FAECAL IMMUNOCHEMICAL TEST IN PEOPLE WITH BENIGN BLEEDING CONDITIONS Erin Symonds, Susanne Pedersen, Joanne Osborne, Geetha Gopalsamy, Snigdha Gaur, David Murray, Aidan McEvoy, Rohan Baker, Stephen Cole, Lawrence LaPointe, Graeme Young 119. A RAPID CLINICAL RESPONSE TO ANTI-TUMOUR NECROSIS FACTOR ALPHA THERAPY IN REFRACTORY CRONKHITE-CANADA SYNDROME Helen Myint, Neeraj Bhala, Nigel Stace 126. ENDOSCOPIC AND HISTOLOGIC FINDINGS IN FOOD BOLUS OBSTRUCTION: NOT ALL EOSINOPHILIC OESOPHAGITIS Alkesh Zala, Steven Bollipo, Marjorie Walker, Nicholas Talley 138. COMPOUNDED LEVOFLOXACIN TRIPLE THERAPY FOR TREATMENT RESISTANT HELICOBACTER PYLORI Vikas Gupta, Srey Neth Loch, David Van Der Poorten 163. VALIDATION OF THE CURRENT LYNCH SYNDROME PREDICTIVE MODELS IN CHINESE POPULATIONS Chun Gan, Mark Jenkins, Finlay Macrae 166. SUCCESS AND TIMECOURSE OF REACHING THE THERAPEUTIC GOALS WITH A GLUTEN-FREE DIET IN COELIAC DISEASE: A PROSPECTIVE FIVE-YEAR STUDY FROM DIAGNOSIS Evan Newnham, Sue Shepherd, Patrick Hosking, Boyd Strauss, Peter Gibson 182. SERVICE AND QUALITY IMPROVEMENT: вЂ�PATIENTS PREFER LOCAL HEALTHCARE’ - WAITING LIST REDUCTION INITIATIVES CONFIRM THAT PATIENTS PREFER вЂ�LOCAL’ HEALTHCARE PROVISION – THE PRINCE CHARLES EXPERIENCE Ann Vandeleur, Joanne Swain, Marelle Best, Sherran Gilani, Gillian Schofield, Belinda Kerwin, Natalie Andrea, Vanessa Campbell, Patricia Fossey, Mark Appleyard, Ruth Hodgson, Tony Rahman 49 Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 50 185. SERVICE AND QUALITY IMPROVEMENT: PROFILING THE FAILURE TO ATTEND PATIENT (FTA), TARGETING RESOURCES AND IMPROVING SERVICE PROVISION DESPITE INCREASED ACTIVITY - THE PRINCE CHARLES EXPERIENCE Ben Law, Patricia Fossey, Ann Vandeleur, Endoscopy Nurses Collabor ENC, Suresh Ponneswamy, John Croese, Mark Appleyard, Ruth Hodgson, Tony Rahman 232. PROSPECTIVE SINGLE-BLINDED SINGLE-CENTRE RANDOMIZED CONTROLLED TRIAL IN COMPARING MOVIPREP, A POLYETHYLENE GLYCOL-BASED SOLUTION WITH PREPKIT C, A COMBINED POLYETHYLENE GLYCOL AND SODIUM PICOSULFATE-BASED SOLUTION IN THE PREPARATION OF PATIENTS FOR COLONO Tady Kordian, Astrid-Jane Greenup, Jenn Hian Kenenth Koo, Wa Sang Ng, Susan Connor 244. DIAGNOSTIC YIELD OF [99M TC] PERTECHNATATE SCINTIGRAPHY SCAN IN ADULTS WITH SUSPECTED MECKEL’S DIVERTICULUM Pruthviraj Uchila, Chiang Siah 249. ESTABLISHMENT OF A FAECAL MICROBIOTA TRANSPLANT SERVICE FOR THE TREATMENT OF RECURRENT CLOSTRIDIUM DIFFICILE COLITIS IN THE AUSTRALIAN PUBLIC HOSPITAL SETTING Samuel Costello, Justin La Brooy, Emily Tucker, Richard Holloway, Mark Schoeman, Jane Andrews 252. HIGH YIELD FOR ADVANCED COLORECTAL NEOPLASIA (CARCINOMA AND ADVANCED ADENOMA) DETECTION WITH COMMUNITY BASED FAECAL IMMUNOCHEMICAL TESTING Samarth Rao, Kannan Venugopal 255. HALO RADIOFREQUENCY ABLATION FOR RESISTANT GASTRIC ANTRAL VASCULAR ECTASIA (GAVE) Eng Gan, Chiang Siah 267. DETECTION OF VARIABLE METHYLATION PATTERNS IMPROVES COLORECTAL CANCER BLOOD TEST SENSITIVITY Rohan Baker, Snigdha Gaur, David Murray, Aidan McEvoy, Graeme Young, Lawrence LaPointe, Susanne Pedersen 279. CHROMOGRANIN A – A USEFUL SCREENING TOOL FOR THE ELUSIVE NEUROENDOCRINE TUMOUR Raphael Luber, Anil Asthana, Sasha Fehily, Peter Gibson 293. SUBSEROSAL EOSINOPHILIC GASTROENTERITIS WITH ASCITES – CASE REPORT OF A RARE DISEASE Wiyang Szetoo, John Ombiga, Peter Boyd, Rachelle Haikings 306. HYDROGEN BREATH TESTS: ARE THEY OVERUTILISED? Hamish Philpott, Emily Nixon, Jarrod Greenhalgh, Sanjay Nandurkar 308. DEVELOPMENT OF NOVEL T-CELL BASED ASSAYS TO IMPROVE THE DETECTION OF COELIAC DISEASE Michael Xiang Ma, Geoffrey Millar Forbes, Jessica Jorritsma, Niamh Keane, Mina John 322. A POTENTIAL CHEMOPREVENTATIVE FOOD FOR FAMILIAL ADENOMATOUS POLYPOSIS: THE AUSFAP STUDY Julie Clarke, Finlay Macrae, Alex Boussioutas, Trevor Lockett 323. CHARACTERISTICS AND OUTCOMES OF OCTOGENARIANS AND NONAGENARIANS DIAGNOSED WITH COLORECTAL CANCER AT A TERTIARY HOSPITAL Claire Gordon, Oyekoya Ayonrinde, Thomas Hendricks, Charitha Ranaweera, Marina Wallace 339. GENETIC VARIATION IN PNPLA3 (RS738409) AND RISK OF ESOPHAGEAL ADENOCARCINOMA Alex Choo, A P Thrift, D C Whiteman, P J Clark Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 MOTILITY/NEUROGASTROENTEROLOGY 40. INTESTINAL MUCOSITIS INDUCED BY 5-FLUOROURACIL RESULTS IN SPINAL ASTROCYTE EXPRESSION CHANGES IN RATS Juliana Bajic, Gordon Howarth, Georgina Eden, Lorrinne Lampton, Suzanne Mashtoub, Mark Hutchinson 170. REFRACTORY GASTROPARESIS CAN BE SUCCESSFULLY MANAGED WITH ENDOSCOPIC TRANSPYLORIC STENT PLACEMENT AND FIXATION Payal Saxena, Vivek Kumbhari, Ahmed Mesallam, Mohamad El Zein, Ahmed Abdelgelil, John Clarke, Anthony Kalloo, Mouen Khashab 195. PERORAL ENDOSCOPIC MYOTOMY (POEM) IS COST EFFECTIVE WHEN COMPARED TO LAPAROSCOPIC HELLER MYOTOMY (LHM) FOR THE TREATMENT OF ACHALASIA Vivek Kumbhari, Payal Saxena, Mohamad El Zein, Manvi Solanki, John Clarke, Anthony Kalloo, Mouen Khashab 196. PNEUMATIC DILATATION (PD) VS. LAPAROSCOPIC HELLER MYOTOMY (LHM) VS. PERORAL ENDOSCOPIC MYOTOMY (POEM) FOR THE TREATMENT OF ACHALASIA: A SINGLE CENTRE EXPERIENCE Vivek Kumbhari, Payal Saxena, Mohamad El Zein, John Clarke, Anthony Kalloo, Mouen Khashab 220. HIGH RESOLUTION MANOMETRIC CORRELATES OF OESOPHAGEAL BOLUS CLEARANCE IN AGEING USING AIM PRESSURE FLOW ANALYSIS Charles Cock, Stamatiki Kritas, Carly Burgstad, Alison Thompson, Laura Besanko, Richard Heddle, Robert Fraser, Taher Omari 275. CAN GASTROENTEROLOGISTS PERFORM POEM SAFELY AND EFFECTIVELY IN THE ENDOSCOPY SUITE WITHOUT A SURGEON? Vivek Kumbhari, Payal Saxena, Mohamad El Zein, Ahmed Abdelgelil, John Clarke, Anthony Kalloo, Mouen Khashab 276. UNDERSTANDING THE MECHANISMS UNDERLYING CHRONIC PAIN IN IBD: A NEW METHOD FOR STUDYING VISCERAL INPUTS FROM THE GASTROINTESTINAL TRACT Kristen Farrell, Brett Graham, Simon Keely, Robert Callister 300. UPDATE ON THE USE OF TRANSCUTANEOUS ELECTRICAL STIMULATION TO OVERCOME FUNCTIONAL MOTILITY DISORDERS Bridget Southwell, Tony Catto-smith, John M Hutson 320. PREDICTORS OF RECURRENT EMERGENCY DEPARTMENT PRESENTATION IN ADULTS WITH CONSTIPATION Adrian Cakra, Samapriya Hewawasam, Angela Khera, Rebecca Burgell 321. CAN Vivek Kumbhari, Payal Saxena, Alan Tieu, Manabu Onimaru, Mohamad El Zein, Rani Modayil, Ezra Teitelbaum, Ahmed Messallam, Matthew Gitelis, Stavros Stavropoulos, Eric Hughness, Michael Ujiki, Hironari Shiwaku, Philip Chiu, Haruhiro Inoue, Moen Khashab NUTRITION 42. ARE CHILDREN ON JEJUNAL FEEDS AT RISK OF IRON DEFICIENCY? Li Zsa Tan, Susan Adams, Alison Kennedy, Felicity Fletcher, Chee Y Ooi 62. FEASIBILITY AND SAFETY OF USING OVERTUBES FOR PEG-TUBE PLACEMENT IN PATIENTS WITH HEAD AND NECK CANCER: A SINGLE-CENTER STUDY Crispin Musumba, Julia Hsu, Golo Ahlenstiel, Nicholas Tutticci, Kavinderjit Nanda, David van der Poorten, Eric Lee, Vu Kwan 51 Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 70. INTENSIVE MEDICAL WEIGHT LOSS PROGRAMME ACHIEVES SIGNIFICANT RAPID PRE-OPERATIVE WEIGHT LOSS IN THE OBESE POPULATION Benedict Devereaux, Christine Skinner, Rachel Myhill, George Hopkins 106. EVALUATION OF SERUM FERRITIN AS A MARKER OF IRON STATUS IN YOUNG AUSTRALIAN ADULTS Elizabeth McKinnon, Anita Chua, Wendy Oddy, Leon Adams, Oyekoya Ayonrinde, John Olynyk 112. HIGH IRON AND TRANSFERRIN SATURATION LEVELS ARE ASSOCIATED WITH INCREASED RISKS OF NON-SKIN CANCERS IN WOMEN Anita Chua, Mark Divitini, Debbie Trinder, Matthew Knuiman, John Olynyk 245. ECONOMIC COSTS OF PARENTERAL NUTRITION WITH A NUTRITIONAL SUPPORT TEAM Jateen Mistry, Andrew Lee, Sally Porter, Michelle Palmer, Susan Ko, Marjoree Sehu, Jeremy Rajanayagam 318. DIETARY RESISTANT STARCH IMPROVES BONE ZINC CONTENT IN RATS REGARDLESS OF ZINC STATUS Geetha Gopalsamy, Graeme Young, Cuong Tran, Elissa Mortimer, Ying Hu PAEDIATRICS 52 12. CAN COELIAC DISEASE BE DIAGNOSED SOLELY BASED ON SEROLOGY? Cheng Hiang Lee, Anja Klasen, Andrew Williams, Kevin Gaskin 32. GASTRO-DUODENAL FISTULA CAUSED BY MULTIPLE MAGNET INGESTION: A CASE REPORT OF SUCCESSFUL ENDOSCOPIC MANAGEMENT IN A CHILD Ajay Sharma, Peggy Marcon, Govind Chavhan, Shyam Mohan, Priscilla Chiu, Pavan Brahmamdan 74. STEROID-FREE REMISSION IN ADALIMUMAB-TREATED PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE IN THE IMAGINE 1 TRIAL Nicolas Martin, Wallace Crandall, Anne Griffiths, Richard Colletti, Frank Ruemmele, William Faubion, Jeffrey Hyams, Andreas Lazar, Yao Li, Samantha Eichner, Roopal Thakkar 118. AN EFFORT TO REDUCE UNNECESSARY COLONOSCOPY IN PAEDIATRIC PATIENTS - A 10 YEAR RETROSPECTIVE AUDIT Patricia Kawada, Edward Vincent O’Loughlin, Michael Oswald Stormon, Shoma Dutt, Annabel Magoffin, Cheng Hiang Lee, Kevin John Gaskin 160. METASTATIC CROHN’S DISEASE IN CHILDREN – SINGLE CENTRE EXPERIENCE Kunal Thacker, Nil Ranwala, Zubin Grover, David Forbes, Catherine Mews, Madhur Ravikumara 194. LONG TERM OUTCOME OF NEONATAL HEMOCHROMATOSIS: A REVIEW OF TWO DECADES OF EXPERIENCE Su Saint Lee, Cheng Hiang Lee, Patricia Kawada, Edward O’Loughlin, Annabel Magoffin, Kevin Gaskin, Michael Stormon 240. ROLE OF ASCA AND ANCA IN PREDICTING THE SEVERITY OF PAEDIATRIC INFLAMMATORY BOWEL DISEASE Shivani Kansal, Josef Wagner, Sarah Thomas, Don Cameron, Mark Oliver, George Alex, Winita Hardikar, Vered Schildkraut, Carl Kirkwood, Anthony Graeme Catto Smith 257. IMPACT OF CAMPYLOBACTER CONCISUS ON PAEDIATRIC INFLAMMATORY BOWEL DISEASE Steven Leach, Lucy Mcmullen, Si Ming Mann, Nadeem Kaakoush, Hazel Mitchell, Daniel Lemberg, Andrew Day 264. TACROLIMUS USE IN PAEDIATRIC INFLAMMATORY BOWEL DISEASE Steven Leach, Rebecca Foster, Daniel Lemberg, Andrew Day Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 307. HOW EFFECTIVE IS COMBINED POLYETHYLENE GLYCOL AND SODIUM PICOSULPHATE FOR DISIMPACTION IN CHILDREN WITH CHRONIC CONSTIPATION AND PALPABLE FAECALOMA? Bridget Southwell, Lauren Dughetti, Julie Jordan-Ely, Lefteris Stathopoulos, Marcello Leal, Tony Catto-Smith, John M Hutson 311. EVALUATION OF THERAPEUTIC вЂ�PLAY PICNICS’ TO MINIMISE THE UNWANTED SIDE EFFECT OF TUBE DEPENDENCY IN ENTERALLY FED CHILDREN Alison Forrest, Lynly Mader, Kate King, Jodi Grunert, Meg Prior 336. COLLAGENOUS GASTRITIS - SERIES OF FOUR PAEDIATRIC CASES FROM A SINGLE INSTITUTION Catherine Mews, Clugston Stephanie, Madhur Ravikumara, David Forbes, Gareth Jevon VIRAL HEPATITIS 52. HAZARDOUS ALCOHOL USE IS MORE STRONGLY ASSOCIATED WITH CIRRHOSIS COMPLICATIONS THAN OBESITY AND DIABETES IN PATIENTS WITH CHRONIC HEPATITIS C: PRELIMINARY RESULTS OF A CASE-CONTROL STUDY Guang Chen, Shivakumar Chitturi, Graham Kaye, Narci Teoh, Geoff Farrell 78. QUAC: Q80K MUTATION PREVALENCE IN AN AUSTRALIAN HEPATITIS C POPULATION Adrian Teck Leng Ong, Jacob George, Mark W Douglas 80. REAL-WORLD EXPERIENCE OF TENOFOVIR AND ENTECAVIR FOR THE TREATMENT OF CHRONIC HEPATITIS B IN A LARGE METROPOLITAN HEALTH SERVICE IN VICTORIA Natasha Janko, Claire Shallue, Catherine Croagh, John Lubel 81. IDENTIFYING CHRONIC HEPATITIS B PATIENTS WHO MAY BE SUITABLE FOR MONITORING IN THE COMMUNITY: PREDICTORS OF STABILITY IN IMMUNE-CONTROL PHASE Natasha Janko, Claire Shallue, Catherine Croagh, John Lubel 91. SAFETY COMPARISON OF 12- AND 24-WEEK TREATMENTS IN HCV GENOTYPE 1-INFECTED PATIENTS WITH CIRRHOSIS: RESULTS FROM TURQUOISE-II Jonathan Anderson, Heiner Wedemeyer, Xavier Forns, Antonio Craxi, Nancy Reau, Paul Kwo, Stefan Bourgeois, Michael Bennett, Stephen Ryder, Dominique Larrey, David Mutimer, Sandra Lovell, Manal Abunimeh, Marcos Pedrosa, Roger Trinh 96. SVR12 OF 99% ACHIEVED WITH A RIBAVIRIN-FREE REGIMEN ABT-450/R/OMBITASVIR AND DASABUVIR IN HCV GENOTYPE 1B –INFECTED PATIENTS Martin Weltman, Andreas Maieron, Massimo Puoti, Jeffrey V Enejosa, Pietro Andreone, Ziv Ben Ari, Gunnar Norkrans, Manuel Romero-Gomez, Wangang Xie, Daniel E Cohen, Thomas Podsadecki 97. VIRAL AND NON-VIRAL FACTORS AFFECTING HEALTH-RELATED QUALITY OF LIFE IN CHRONIC HEPATITIS C Kendall Williams, Adele Hampson, Thomas Lee, Ria Kanazaki, Omar Sharaiha, Heidi Cheung, Micaela Lucas 99. ADVERSE EVENT PROFILE OF THE INTERFERON-FREE ALL-ORAL ABT-450/R/OMBITASVIR, DASABUVIR, AND RIBAVIRIN REGIMEN IN HCV PATIENTS Jacob George, Donald Jensen, Tolga Baykal, Eric Lawitz, Jordan Feld, Gioacchino Angarano, Saumya Jayakumar, Tania Welzel, Eoin Coakley, Julia Xiong, Barbara Da Silva-Tillmann, Lois Larsen 53 Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 54 120. PATIENTS LOST TO FOLLOW UP: THE EXPERIENCE OF AN AUSTRALIAN HEPATITIS B CLINIC Phil Ha, Vanessa Bull, Natassia Tan, Stephanie Spring, Lukas Sahhar, Suong Le, Anouk Dev 142. SUCCESSFUL TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1 WITH TRIPLE THERAPY USING DIRECT ANTIVIRAL AGENTS, IN RURAL AND REMOTE REGIONAL WESTERN AUSTRALIA (WA) Chandrin Jayasundera, Lydia Scott, Stephen Hinton, Camilla Hey, Lesley Norman, Charles Greenfield, Saroj Nazareth, Mya Yee, John Lindsey, Jaye Martin, Wendy Cheng 150. FACTORS ASSOCIATED WITH COMPLIANCE AND ADHERENCE IN THE TREATMENT OF CHRONIC HEPATITIS C INFECTION AT A TERTIARY CENTRE Sherman Picardo, Nick Kontorinis, Lorenzo Tarquinio, Jee Kong, Saroj Nazareth, Wendy Cheng 152. LONG-TERM “REAL WORLD” EXPERIENCE WITH TENOFOVIR AND ENTECAVIR IN THE TREATMENT OF CHRONIC HEPATITIS B: A WESTERN AUSTRALIAN TERTIARY CENTRE EXPERIENCE Sherman Picardo, Zi Ng, Samarth Rao, James Flexman, Nick Kontorinis, Lorenzo Tarquinio, Jee Kong, Wendy Cheng 159. HEALTH AND ECONOMICAL IMPACT OF OCCUPATIONAL INJURIES FROM HEPATITIS C POSITIVE SOURCES OVER TWO DECADES IN A TERTIARY HOSPITAL SETTING Astrid-Jane Greenup 178. THE GOOD RESPONSE IL28B GENOTYPE IS ASSOCIATED WITH HIGH GRADE LIVER NECROINFLAMMATION AND INCREASED EXPRESSION OF THE CHEMOKINE CXCL9 IN LIVER AND PLASMA Jacinta Holmes, Narelle Skinner, Mario Congiu, Rosemary Millen, Sally Bell, Tin Nguyen, David Iser, Scott Bowden, William Sievert, Paul Desmond, Kumar Visvanathan, Alexander Thompson 189. ELDERLY AGE IS NOT ASSOCIATED WITH REDUCED SUSTAINED VIROLOGICAL RESPONSE IN THE TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C INFECTION Sherman Picardo, Nick Kontorinis, Lorenzo Tarquinio, Jee Kong, Saroj Nazareth, Rhoda Tuma, Wendy Cheng 190. MAPPING THE HBSAG IMMUNE PHENOTYPE TO PREDICT HBSAG DECLINE IN CHRONIC HEPATITIS B IN PATIENTS RECEIVING NUCLEOT(S)IDE ANALOGUE THERAPY Lucy Lim, Lilly Yuen, Rachel Hammond, Peter Angus, Alexander Thompson, Scott Patterson, Tom Leary, Peng Yi, Howard Thomas, Stephen Locarnini, Renae Walsh 201. THE CHANGING PROFILE OF PATIENTS WITH CHRONIC HEPATITIS C INFECTION TREATED AT A TERTIARY CENTRE IN WESTERN AUSTRALIA OVER THE LAST DECADE Sherman Picardo, Nick Kontorinis, Lorenzo Tarquinio, Jee Kong, Saroj Nazareth, Rhoda Tuma, Marion McInerney, Terri Budge, Sook-Ling Chen, Nadine Leembruggen, Nigel Armstrong, Alexandra Welborn, James Flexman, Wendy Cheng 204. DEFICIENCIES IN THE CURRENT CLASSIFICATION OF CHRONIC HEPATITIS B PHASES: EXPERIENCES FROM REAL-WORLD PRACTICE Natasha Janko, Claire Shallue, Catherine Croagh, John Lubel 263. THE EFFECTS OF TENOFOVIR AND ENTECAVIR ON RENAL FUNCTION IN PATIENTS WITH CHRONIC HEPATITIS B TREATED FOR TWO YEARS AT A TERTIARY CENTRE Zi Yun Ng, Jee Yuen Kong, Nick Kontorinis, Lorenzo Tarquinio, Sam Rao, Sherman Picardo, James Flexman, Wendy Cheng 265. ABSTRACT: METALLOTHIONEINS MODULATE HCV REPLICATION AND IFNL3 MEDIATED ANTIVIRAL RESPONSE Scott Read, Kate O’Connor, Mark Douglas, David Booth, Jacob George, Golo Ahlenstiel Australian Gastroenterology Week 2014 Gold Coast Convention & Exhibition Centre, Gold Coast, Queensland, 22 – 24 October 2014 285. THE CORRELATION BETWEEN HEPASCORE AND FIBROSCANВ® IN PATIENTS WITH CHRONIC VIRAL HEPATITIS Sherman Picardo, Jee Kong, Nick Kontorinis, Lorenzo Tarquinio, Leon Adams, Saroj Nazareth, Nadine Leembruggen, Terri Budge, Sook Ling Chen, Wendy Cheng 313. AN ENTECAVIR (ETV) AND TENOFOVIR (TDF) REAL WORLD STUDY – A RETROSPECTIVE REVIEW OF LONG TERM ENTECAVIR AND TENOFOVIR THERAPY IN CHRONIC HEPATITIS B IN AUSTRALIA Rebekah Van Leest 55
© Copyright 2024 Paperzz